PRJNA375882: Comprehensive Mouse Transcriptomic BodyMap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Spi1
|
ENSMUSG00000002111.9 | Spi1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Spi1 | mm39_v1_chr2_+_90912710_90912735 | 0.75 | 3.7e-14 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr7_-_126736979 | 29.43 |
ENSMUST00000049931.6
|
Spn
|
sialophorin |
chr17_+_34809132 | 29.09 |
ENSMUST00000173772.2
|
Gpsm3
|
G-protein signalling modulator 3 (AGS3-like, C. elegans) |
chr7_-_126817475 | 27.67 |
ENSMUST00000106313.8
ENSMUST00000142356.3 |
Septin1
|
septin 1 |
chr1_-_138103021 | 27.24 |
ENSMUST00000182755.8
ENSMUST00000193650.2 ENSMUST00000182283.8 |
Ptprc
|
protein tyrosine phosphatase, receptor type, C |
chr1_-_138102972 | 27.20 |
ENSMUST00000195533.6
ENSMUST00000183301.8 |
Ptprc
|
protein tyrosine phosphatase, receptor type, C |
chr7_-_126817639 | 26.17 |
ENSMUST00000152267.8
ENSMUST00000106314.8 |
Septin1
|
septin 1 |
chr15_+_78128990 | 24.87 |
ENSMUST00000096357.12
|
Ncf4
|
neutrophil cytosolic factor 4 |
chr1_+_130793406 | 24.38 |
ENSMUST00000038829.7
|
Fcmr
|
Fc fragment of IgM receptor |
chr17_+_34808772 | 23.80 |
ENSMUST00000038244.15
|
Gpsm3
|
G-protein signalling modulator 3 (AGS3-like, C. elegans) |
chr11_-_83483807 | 20.21 |
ENSMUST00000019071.4
|
Ccl6
|
chemokine (C-C motif) ligand 6 |
chr19_+_4204605 | 19.34 |
ENSMUST00000061086.9
|
Ptprcap
|
protein tyrosine phosphatase, receptor type, C polypeptide-associated protein |
chr14_-_70412804 | 18.38 |
ENSMUST00000143393.2
|
Pdlim2
|
PDZ and LIM domain 2 |
chr11_+_11635908 | 18.08 |
ENSMUST00000065433.12
|
Ikzf1
|
IKAROS family zinc finger 1 |
chr11_+_95733489 | 17.54 |
ENSMUST00000100532.10
ENSMUST00000036088.11 |
Gngt2
|
guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2 |
chr15_+_78129040 | 17.52 |
ENSMUST00000133618.3
|
Ncf4
|
neutrophil cytosolic factor 4 |
chr7_+_142014546 | 17.36 |
ENSMUST00000105968.8
ENSMUST00000018963.11 ENSMUST00000105967.8 |
Lsp1
|
lymphocyte specific 1 |
chr3_-_90603013 | 16.74 |
ENSMUST00000069960.12
ENSMUST00000117167.2 |
S100a9
|
S100 calcium binding protein A9 (calgranulin B) |
chr9_+_89081262 | 16.14 |
ENSMUST00000068569.5
|
Bcl2a1b
|
B cell leukemia/lymphoma 2 related protein A1b |
chr3_+_90576285 | 15.85 |
ENSMUST00000069927.10
|
S100a8
|
S100 calcium binding protein A8 (calgranulin A) |
chr11_+_33996920 | 15.65 |
ENSMUST00000052413.12
|
Lcp2
|
lymphocyte cytosolic protein 2 |
chr6_-_136918844 | 15.16 |
ENSMUST00000204934.2
|
Arhgdib
|
Rho, GDP dissociation inhibitor (GDI) beta |
chr9_-_88613967 | 14.96 |
ENSMUST00000098486.4
|
Bcl2a1d
|
B cell leukemia/lymphoma 2 related protein A1d |
chr13_-_37233179 | 14.75 |
ENSMUST00000037491.11
|
F13a1
|
coagulation factor XIII, A1 subunit |
chr11_+_33997114 | 14.66 |
ENSMUST00000109329.9
|
Lcp2
|
lymphocyte cytosolic protein 2 |
chrX_+_47235313 | 14.63 |
ENSMUST00000033427.7
|
Sash3
|
SAM and SH3 domain containing 3 |
chr11_-_79414542 | 14.35 |
ENSMUST00000179322.2
|
Evi2b
|
ecotropic viral integration site 2b |
chr6_-_124715618 | 14.28 |
ENSMUST00000171549.9
|
Ptpn6
|
protein tyrosine phosphatase, non-receptor type 6 |
chr7_-_44888532 | 14.16 |
ENSMUST00000033063.15
|
Cd37
|
CD37 antigen |
chr1_+_135060431 | 14.10 |
ENSMUST00000187985.7
ENSMUST00000049449.11 |
Ptpn7
|
protein tyrosine phosphatase, non-receptor type 7 |
chr1_+_51328265 | 14.08 |
ENSMUST00000051572.8
|
Cavin2
|
caveolae associated 2 |
chr12_-_112824506 | 13.96 |
ENSMUST00000021729.9
|
Gpr132
|
G protein-coupled receptor 132 |
chr11_+_95733109 | 13.92 |
ENSMUST00000107714.9
ENSMUST00000107711.8 |
Gngt2
|
guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2 |
chr7_-_44888220 | 13.86 |
ENSMUST00000210372.2
ENSMUST00000209779.2 ENSMUST00000098461.10 ENSMUST00000211373.2 |
Cd37
|
CD37 antigen |
chrX_-_100311824 | 13.79 |
ENSMUST00000033664.14
|
Il2rg
|
interleukin 2 receptor, gamma chain |
chr14_+_79753055 | 13.71 |
ENSMUST00000110835.3
ENSMUST00000227192.2 |
Elf1
|
E74-like factor 1 |
chr6_-_124715560 | 13.70 |
ENSMUST00000004377.15
|
Ptpn6
|
protein tyrosine phosphatase, non-receptor type 6 |
chr11_-_120622770 | 13.54 |
ENSMUST00000154565.2
ENSMUST00000026148.9 |
Cbr2
|
carbonyl reductase 2 |
chr6_-_124715542 | 13.41 |
ENSMUST00000174265.2
|
Ptpn6
|
protein tyrosine phosphatase, non-receptor type 6 |
chr6_-_136918671 | 13.40 |
ENSMUST00000032344.12
|
Arhgdib
|
Rho, GDP dissociation inhibitor (GDI) beta |
chr14_-_56026266 | 13.35 |
ENSMUST00000168716.8
ENSMUST00000178399.3 ENSMUST00000022830.14 |
Ripk3
|
receptor-interacting serine-threonine kinase 3 |
chr7_-_44888465 | 13.31 |
ENSMUST00000210078.2
|
Cd37
|
CD37 antigen |
chr19_-_6835538 | 13.24 |
ENSMUST00000113440.2
|
Ccdc88b
|
coiled-coil domain containing 88B |
chr8_+_95650315 | 13.08 |
ENSMUST00000153448.9
ENSMUST00000166802.9 ENSMUST00000074570.10 |
Adgrg5
|
adhesion G protein-coupled receptor G5 |
chr15_-_78456898 | 13.02 |
ENSMUST00000043214.8
|
Rac2
|
Rac family small GTPase 2 |
chr19_-_11243530 | 12.98 |
ENSMUST00000169159.3
|
Ms4a1
|
membrane-spanning 4-domains, subfamily A, member 1 |
chr5_-_140986312 | 12.89 |
ENSMUST00000085786.7
|
Card11
|
caspase recruitment domain family, member 11 |
chr14_+_53186025 | 12.77 |
ENSMUST00000196802.2
|
Trav14d-2
|
T cell receptor alpha variable 14D-2 |
chr9_-_22042930 | 12.70 |
ENSMUST00000213815.2
|
Acp5
|
acid phosphatase 5, tartrate resistant |
chr2_-_118558852 | 12.65 |
ENSMUST00000102524.8
|
Plcb2
|
phospholipase C, beta 2 |
chr3_-_106126794 | 12.62 |
ENSMUST00000082219.6
|
Chil4
|
chitinase-like 4 |
chr11_+_61017573 | 12.62 |
ENSMUST00000010286.8
ENSMUST00000146033.8 ENSMUST00000139422.8 |
Tnfrsf13b
|
tumor necrosis factor receptor superfamily, member 13b |
chr15_+_78481247 | 12.56 |
ENSMUST00000043069.6
ENSMUST00000231180.2 ENSMUST00000229796.2 ENSMUST00000229295.2 |
Cyth4
|
cytohesin 4 |
chr16_-_19801781 | 12.53 |
ENSMUST00000058839.10
|
Klhl6
|
kelch-like 6 |
chr14_+_53404083 | 12.50 |
ENSMUST00000196639.2
ENSMUST00000177578.2 |
Trav14n-1
|
T cell receptor alpha variable 14N-1 |
chr9_-_44920899 | 12.50 |
ENSMUST00000102832.3
|
Cd3e
|
CD3 antigen, epsilon polypeptide |
chr6_-_16898440 | 12.46 |
ENSMUST00000031533.11
|
Tfec
|
transcription factor EC |
chrX_+_106193167 | 12.44 |
ENSMUST00000137107.2
ENSMUST00000067249.3 |
P2ry10b
|
purinergic receptor P2Y, G-protein coupled 10B |
chr10_+_61133549 | 12.42 |
ENSMUST00000219375.2
|
Prf1
|
perforin 1 (pore forming protein) |
chr2_+_127178072 | 12.42 |
ENSMUST00000028846.7
|
Dusp2
|
dual specificity phosphatase 2 |
chr9_+_44893077 | 12.20 |
ENSMUST00000034602.9
|
Cd3d
|
CD3 antigen, delta polypeptide |
chr7_+_24069680 | 12.19 |
ENSMUST00000205428.2
ENSMUST00000171904.3 ENSMUST00000205626.2 |
Kcnn4
|
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
chr15_+_84208915 | 12.15 |
ENSMUST00000023074.9
|
Parvg
|
parvin, gamma |
chr1_-_192883642 | 12.11 |
ENSMUST00000192020.6
|
Traf3ip3
|
TRAF3 interacting protein 3 |
chr1_-_69723316 | 12.04 |
ENSMUST00000190855.7
ENSMUST00000188110.7 ENSMUST00000191262.7 |
Ikzf2
|
IKAROS family zinc finger 2 |
chr9_+_88838953 | 11.98 |
ENSMUST00000098485.4
|
Bcl2a1a
|
B cell leukemia/lymphoma 2 related protein A1a |
chr7_-_80037153 | 11.95 |
ENSMUST00000206728.2
|
Fes
|
feline sarcoma oncogene |
chr7_-_83304698 | 11.86 |
ENSMUST00000145610.8
|
Il16
|
interleukin 16 |
chr7_+_43057611 | 11.86 |
ENSMUST00000005592.7
|
Siglecg
|
sialic acid binding Ig-like lectin G |
chr7_+_24596806 | 11.77 |
ENSMUST00000003469.8
|
Cd79a
|
CD79A antigen (immunoglobulin-associated alpha) |
chr7_-_101899294 | 11.76 |
ENSMUST00000106923.2
ENSMUST00000098230.11 |
Rhog
|
ras homolog family member G |
chr2_+_172864153 | 11.74 |
ENSMUST00000173997.2
|
Rbm38
|
RNA binding motif protein 38 |
chr17_+_27276262 | 11.69 |
ENSMUST00000049308.9
|
Itpr3
|
inositol 1,4,5-triphosphate receptor 3 |
chr19_-_4240984 | 11.61 |
ENSMUST00000045864.4
|
Tbc1d10c
|
TBC1 domain family, member 10c |
chr3_-_106697459 | 11.61 |
ENSMUST00000038845.10
|
Cd53
|
CD53 antigen |
chr12_-_113386312 | 11.44 |
ENSMUST00000177715.8
ENSMUST00000103426.3 |
Ighm
|
immunoglobulin heavy constant mu |
chr9_+_110867807 | 11.41 |
ENSMUST00000197575.2
|
Ltf
|
lactotransferrin |
chr7_+_126895423 | 11.24 |
ENSMUST00000117762.8
|
Itgal
|
integrin alpha L |
chr4_-_129452148 | 11.19 |
ENSMUST00000167288.8
ENSMUST00000134336.3 |
Lck
|
lymphocyte protein tyrosine kinase |
chrX_+_106193060 | 11.14 |
ENSMUST00000125676.8
ENSMUST00000180182.2 |
P2ry10b
|
purinergic receptor P2Y, G-protein coupled 10B |
chr4_-_129452180 | 11.07 |
ENSMUST00000067240.11
|
Lck
|
lymphocyte protein tyrosine kinase |
chr19_-_10807409 | 11.07 |
ENSMUST00000080292.12
|
Cd6
|
CD6 antigen |
chr10_+_127157784 | 10.96 |
ENSMUST00000219511.2
|
Arhgap9
|
Rho GTPase activating protein 9 |
chr7_-_120673761 | 10.94 |
ENSMUST00000047194.4
|
Igsf6
|
immunoglobulin superfamily, member 6 |
chr6_+_17065141 | 10.86 |
ENSMUST00000115467.11
ENSMUST00000154266.3 ENSMUST00000076654.9 |
Tes
|
testin LIM domain protein |
chr2_-_25086810 | 10.81 |
ENSMUST00000081869.7
|
Tor4a
|
torsin family 4, member A |
chr1_-_170755136 | 10.80 |
ENSMUST00000046322.14
ENSMUST00000159171.2 |
Fcrla
|
Fc receptor-like A |
chr1_-_95595280 | 10.78 |
ENSMUST00000043336.11
|
St8sia4
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 |
chr9_-_22043083 | 10.78 |
ENSMUST00000069330.14
ENSMUST00000217643.2 |
Acp5
|
acid phosphatase 5, tartrate resistant |
chr6_+_124807176 | 10.70 |
ENSMUST00000131847.8
ENSMUST00000151674.3 |
Cdca3
|
cell division cycle associated 3 |
chr11_-_99045894 | 10.66 |
ENSMUST00000103134.4
|
Ccr7
|
chemokine (C-C motif) receptor 7 |
chr6_+_70703409 | 10.61 |
ENSMUST00000103410.3
|
Igkc
|
immunoglobulin kappa constant |
chr19_-_34231600 | 10.60 |
ENSMUST00000238147.2
|
Acta2
|
actin, alpha 2, smooth muscle, aorta |
chr3_-_137687284 | 10.43 |
ENSMUST00000136613.4
ENSMUST00000029806.13 |
Dapp1
|
dual adaptor for phosphotyrosine and 3-phosphoinositides 1 |
chr2_-_25086770 | 10.42 |
ENSMUST00000142857.2
ENSMUST00000137920.2 |
Tor4a
|
torsin family 4, member A |
chr15_+_101310283 | 10.42 |
ENSMUST00000068904.9
|
Krt7
|
keratin 7 |
chr8_+_106786190 | 10.41 |
ENSMUST00000109308.3
|
Nfatc3
|
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 3 |
chr2_+_172863688 | 10.37 |
ENSMUST00000029014.16
|
Rbm38
|
RNA binding motif protein 38 |
chr7_+_126895463 | 10.29 |
ENSMUST00000106306.9
ENSMUST00000120857.8 |
Itgal
|
integrin alpha L |
chr1_-_165535617 | 10.28 |
ENSMUST00000040357.11
|
Rcsd1
|
RCSD domain containing 1 |
chr17_+_34311314 | 10.19 |
ENSMUST00000025192.8
|
H2-Oa
|
histocompatibility 2, O region alpha locus |
chr19_-_10807285 | 10.18 |
ENSMUST00000039043.15
|
Cd6
|
CD6 antigen |
chr19_-_4241034 | 10.17 |
ENSMUST00000237495.2
|
Tbc1d10c
|
TBC1 domain family, member 10c |
chr3_+_87283687 | 10.15 |
ENSMUST00000163661.8
ENSMUST00000072480.9 |
Fcrl1
|
Fc receptor-like 1 |
chr1_-_131204651 | 10.14 |
ENSMUST00000161764.8
|
Ikbke
|
inhibitor of kappaB kinase epsilon |
chr13_-_19491721 | 10.13 |
ENSMUST00000103561.3
|
Trgc2
|
T cell receptor gamma, constant 2 |
chr2_+_22664094 | 10.11 |
ENSMUST00000014290.15
|
Apbb1ip
|
amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein |
chr17_+_33774681 | 10.09 |
ENSMUST00000087605.13
ENSMUST00000174695.2 |
Myo1f
|
myosin IF |
chrX_+_95139639 | 10.05 |
ENSMUST00000117399.2
|
Msn
|
moesin |
chr14_+_53878158 | 10.04 |
ENSMUST00000179267.4
|
Trav14-2
|
T cell receptor alpha variable 14-2 |
chr1_-_192883743 | 10.02 |
ENSMUST00000043550.11
|
Traf3ip3
|
TRAF3 interacting protein 3 |
chr2_+_84810802 | 10.01 |
ENSMUST00000028467.6
|
Prg2
|
proteoglycan 2, bone marrow |
chr7_+_18618605 | 9.99 |
ENSMUST00000032573.8
|
Pglyrp1
|
peptidoglycan recognition protein 1 |
chr14_+_51366512 | 9.93 |
ENSMUST00000095923.4
|
Rnase6
|
ribonuclease, RNase A family, 6 |
chr19_-_10716335 | 9.90 |
ENSMUST00000025571.9
ENSMUST00000238167.2 |
Cd5
|
CD5 antigen |
chr9_-_123768720 | 9.88 |
ENSMUST00000026911.6
|
Ccr1
|
chemokine (C-C motif) receptor 1 |
chr5_-_107873883 | 9.88 |
ENSMUST00000159263.3
|
Gfi1
|
growth factor independent 1 transcription repressor |
chr11_-_34674677 | 9.85 |
ENSMUST00000093193.12
ENSMUST00000101365.9 |
Dock2
|
dedicator of cyto-kinesis 2 |
chr9_+_89081407 | 9.85 |
ENSMUST00000138109.2
|
Gm29094
|
predicted gene 29094 |
chr2_+_84670543 | 9.85 |
ENSMUST00000111624.8
|
Slc43a1
|
solute carrier family 43, member 1 |
chr11_+_21041291 | 9.84 |
ENSMUST00000093290.12
|
Peli1
|
pellino 1 |
chr13_-_110493665 | 9.81 |
ENSMUST00000058806.7
ENSMUST00000224534.2 |
Gapt
|
Grb2-binding adaptor, transmembrane |
chr2_+_84670956 | 9.76 |
ENSMUST00000111625.2
|
Slc43a1
|
solute carrier family 43, member 1 |
chr11_-_6470918 | 9.75 |
ENSMUST00000003459.4
|
Myo1g
|
myosin IG |
chr3_+_106393348 | 9.75 |
ENSMUST00000183271.2
|
Dennd2d
|
DENN/MADD domain containing 2D |
chr15_-_66673425 | 9.74 |
ENSMUST00000168589.8
|
Sla
|
src-like adaptor |
chr1_+_152683627 | 9.73 |
ENSMUST00000027754.7
|
Ncf2
|
neutrophil cytosolic factor 2 |
chr9_-_32452885 | 9.71 |
ENSMUST00000016231.14
|
Fli1
|
Friend leukemia integration 1 |
chr13_-_12535236 | 9.68 |
ENSMUST00000179308.3
|
Edaradd
|
EDAR (ectodysplasin-A receptor)-associated death domain |
chr1_+_159871943 | 9.67 |
ENSMUST00000163892.8
|
4930523C07Rik
|
RIKEN cDNA 4930523C07 gene |
chr17_-_35420972 | 9.65 |
ENSMUST00000167924.2
ENSMUST00000025263.15 |
Tnf
|
tumor necrosis factor |
chr1_-_53824307 | 9.61 |
ENSMUST00000185920.2
|
Stk17b
|
serine/threonine kinase 17b (apoptosis-inducing) |
chr17_+_35268942 | 9.60 |
ENSMUST00000007257.10
|
Clic1
|
chloride intracellular channel 1 |
chr9_+_55997246 | 9.58 |
ENSMUST00000059206.8
|
Pstpip1
|
proline-serine-threonine phosphatase-interacting protein 1 |
chr1_-_171434882 | 9.51 |
ENSMUST00000111277.2
ENSMUST00000004827.14 |
Ly9
|
lymphocyte antigen 9 |
chr14_-_68893253 | 9.50 |
ENSMUST00000225767.3
ENSMUST00000111072.8 ENSMUST00000022642.6 ENSMUST00000224039.2 |
Adam28
|
a disintegrin and metallopeptidase domain 28 |
chrX_+_106132840 | 9.49 |
ENSMUST00000118666.8
ENSMUST00000053375.4 |
P2ry10
|
purinergic receptor P2Y, G-protein coupled 10 |
chr1_-_53824373 | 9.48 |
ENSMUST00000027263.14
|
Stk17b
|
serine/threonine kinase 17b (apoptosis-inducing) |
chr16_+_36755338 | 9.48 |
ENSMUST00000023531.15
|
Hcls1
|
hematopoietic cell specific Lyn substrate 1 |
chr10_+_127159609 | 9.33 |
ENSMUST00000069548.7
|
Arhgap9
|
Rho GTPase activating protein 9 |
chr2_-_126333450 | 9.33 |
ENSMUST00000040149.13
|
Atp8b4
|
ATPase, class I, type 8B, member 4 |
chr10_+_127159568 | 9.28 |
ENSMUST00000219026.2
|
Arhgap9
|
Rho GTPase activating protein 9 |
chrX_+_106299484 | 9.23 |
ENSMUST00000101294.9
ENSMUST00000118820.8 ENSMUST00000120971.8 |
Gpr174
|
G protein-coupled receptor 174 |
chr17_-_57385490 | 9.21 |
ENSMUST00000011623.9
|
Dennd1c
|
DENN/MADD domain containing 1C |
chr17_+_47816042 | 9.18 |
ENSMUST00000183044.8
ENSMUST00000037333.17 |
Ccnd3
|
cyclin D3 |
chr14_+_53791444 | 9.18 |
ENSMUST00000198297.2
|
Trav14-1
|
T cell receptor alpha variable 14-1 |
chr6_+_60921456 | 9.18 |
ENSMUST00000129603.4
ENSMUST00000204333.2 |
Mmrn1
|
multimerin 1 |
chrX_-_56384089 | 9.16 |
ENSMUST00000033468.11
|
Arhgef6
|
Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6 |
chr15_-_100567377 | 9.11 |
ENSMUST00000182814.8
ENSMUST00000238935.2 ENSMUST00000182068.8 ENSMUST00000182574.2 ENSMUST00000182775.8 |
Bin2
|
bridging integrator 2 |
chr3_+_87283767 | 9.09 |
ENSMUST00000194786.6
ENSMUST00000191666.2 |
Fcrl1
|
Fc receptor-like 1 |
chr4_-_63321591 | 9.08 |
ENSMUST00000035724.5
|
Akna
|
AT-hook transcription factor |
chrX_-_7956682 | 9.01 |
ENSMUST00000033505.7
|
Was
|
Wiskott-Aldrich syndrome |
chr7_+_126895531 | 8.97 |
ENSMUST00000170971.8
|
Itgal
|
integrin alpha L |
chr14_+_53607470 | 8.96 |
ENSMUST00000103652.5
|
Trav14n-3
|
T cell receptor alpha variable 14N-3 |
chr11_+_61544085 | 8.93 |
ENSMUST00000004959.3
|
Grap
|
GRB2-related adaptor protein |
chr6_+_135339543 | 8.91 |
ENSMUST00000205156.3
|
Emp1
|
epithelial membrane protein 1 |
chr12_-_32258604 | 8.91 |
ENSMUST00000053215.14
|
Pik3cg
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma |
chr5_+_86219593 | 8.85 |
ENSMUST00000198435.5
ENSMUST00000031171.9 |
Stap1
|
signal transducing adaptor family member 1 |
chr2_+_90927053 | 8.85 |
ENSMUST00000132741.3
|
Spi1
|
spleen focus forming virus (SFFV) proviral integration oncogene |
chr19_-_6996791 | 8.85 |
ENSMUST00000040772.9
|
Fermt3
|
fermitin family member 3 |
chr2_+_11647610 | 8.79 |
ENSMUST00000028111.6
|
Il2ra
|
interleukin 2 receptor, alpha chain |
chr1_-_171434944 | 8.77 |
ENSMUST00000068878.14
|
Ly9
|
lymphocyte antigen 9 |
chr15_-_102140331 | 8.77 |
ENSMUST00000230652.2
ENSMUST00000127014.3 ENSMUST00000001327.11 |
Itgb7
|
integrin beta 7 |
chr3_+_84573499 | 8.74 |
ENSMUST00000107682.2
|
Tmem154
|
transmembrane protein 154 |
chr6_+_41139948 | 8.72 |
ENSMUST00000103275.4
|
Trbv17
|
T cell receptor beta, variable 17 |
chr1_-_133617824 | 8.72 |
ENSMUST00000189524.2
ENSMUST00000169295.8 |
Lax1
|
lymphocyte transmembrane adaptor 1 |
chr17_+_35413415 | 8.72 |
ENSMUST00000025262.6
ENSMUST00000173600.2 |
Ltb
|
lymphotoxin B |
chr7_+_126690525 | 8.71 |
ENSMUST00000056288.7
ENSMUST00000206102.2 |
AI467606
|
expressed sequence AI467606 |
chr13_+_30933209 | 8.70 |
ENSMUST00000021784.10
ENSMUST00000110307.3 ENSMUST00000222125.2 |
Irf4
|
interferon regulatory factor 4 |
chr6_+_41511248 | 8.69 |
ENSMUST00000192366.2
ENSMUST00000103286.2 |
Trbj1-3
|
T cell receptor beta joining 1-3 |
chr12_+_113115632 | 8.69 |
ENSMUST00000006523.12
ENSMUST00000200553.2 |
Crip1
|
cysteine-rich protein 1 (intestinal) |
chr6_+_48715971 | 8.68 |
ENSMUST00000054368.7
ENSMUST00000140054.3 ENSMUST00000204168.2 ENSMUST00000204408.2 |
Gimap1
Gm28053
|
GTPase, IMAP family member 1 predicted gene, 28053 |
chr1_+_172327812 | 8.67 |
ENSMUST00000192460.2
|
Tagln2
|
transgelin 2 |
chr1_+_172302925 | 8.65 |
ENSMUST00000027830.5
|
Slamf9
|
SLAM family member 9 |
chr3_+_87283748 | 8.65 |
ENSMUST00000167200.7
|
Fcrl1
|
Fc receptor-like 1 |
chr10_+_79824418 | 8.64 |
ENSMUST00000004784.11
ENSMUST00000105374.2 |
Cnn2
|
calponin 2 |
chr7_+_127728712 | 8.63 |
ENSMUST00000033053.8
ENSMUST00000205460.2 |
Itgax
|
integrin alpha X |
chr6_+_41024260 | 8.62 |
ENSMUST00000103263.3
|
Trbv2
|
T cell receptor beta, variable 2 |
chr16_-_75706161 | 8.54 |
ENSMUST00000114239.9
|
Samsn1
|
SAM domain, SH3 domain and nuclear localization signals, 1 |
chr2_+_24276616 | 8.54 |
ENSMUST00000166388.2
|
Psd4
|
pleckstrin and Sec7 domain containing 4 |
chr1_+_171509565 | 8.53 |
ENSMUST00000015499.14
ENSMUST00000068584.7 |
Cd48
|
CD48 antigen |
chr5_-_137869969 | 8.51 |
ENSMUST00000196162.5
|
Pilrb2
|
paired immunoglobin-like type 2 receptor beta 2 |
chr17_+_48761916 | 8.47 |
ENSMUST00000074574.13
|
Unc5cl
|
unc-5 family C-terminal like |
chr4_+_130640436 | 8.45 |
ENSMUST00000151698.8
|
Laptm5
|
lysosomal-associated protein transmembrane 5 |
chr7_-_127593003 | 8.43 |
ENSMUST00000033056.5
|
Pycard
|
PYD and CARD domain containing |
chr1_+_34511793 | 8.41 |
ENSMUST00000188972.3
|
Ptpn18
|
protein tyrosine phosphatase, non-receptor type 18 |
chr1_+_61017057 | 8.40 |
ENSMUST00000027162.12
ENSMUST00000102827.4 |
Icos
|
inducible T cell co-stimulator |
chr4_+_66745803 | 8.40 |
ENSMUST00000048096.12
ENSMUST00000107365.3 |
Tlr4
|
toll-like receptor 4 |
chr17_+_47816074 | 8.38 |
ENSMUST00000183177.8
ENSMUST00000182848.8 |
Ccnd3
|
cyclin D3 |
chr2_-_26250886 | 8.34 |
ENSMUST00000028294.7
|
Card9
|
caspase recruitment domain family, member 9 |
chr10_+_7708178 | 8.32 |
ENSMUST00000039484.6
|
Zc3h12d
|
zinc finger CCCH type containing 12D |
chr15_-_66432938 | 8.27 |
ENSMUST00000048372.7
|
Tmem71
|
transmembrane protein 71 |
chr1_+_165616250 | 8.25 |
ENSMUST00000161971.8
ENSMUST00000187313.7 ENSMUST00000178336.8 ENSMUST00000005907.12 ENSMUST00000027849.11 |
Cd247
|
CD247 antigen |
chr8_+_73488496 | 8.23 |
ENSMUST00000058099.9
|
F2rl3
|
coagulation factor II (thrombin) receptor-like 3 |
chr2_-_118558825 | 8.16 |
ENSMUST00000159756.2
|
Plcb2
|
phospholipase C, beta 2 |
chr6_+_41098273 | 8.16 |
ENSMUST00000103270.4
|
Trbv13-2
|
T cell receptor beta, variable 13-2 |
chr1_-_131204422 | 8.15 |
ENSMUST00000159195.2
|
Ikbke
|
inhibitor of kappaB kinase epsilon |
chr6_-_87473260 | 8.10 |
ENSMUST00000101197.9
|
Arhgap25
|
Rho GTPase activating protein 25 |
chr1_+_134110142 | 8.10 |
ENSMUST00000082060.10
ENSMUST00000153856.8 ENSMUST00000133701.8 ENSMUST00000132873.8 |
Chil1
|
chitinase-like 1 |
chr2_+_165436929 | 8.10 |
ENSMUST00000088132.13
|
Eya2
|
EYA transcriptional coactivator and phosphatase 2 |
chr7_-_103928939 | 8.10 |
ENSMUST00000051795.10
|
Trim5
|
tripartite motif-containing 5 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
15.4 | 61.7 | GO:2000471 | regulation of hematopoietic stem cell migration(GO:2000471) positive regulation of hematopoietic stem cell migration(GO:2000473) |
9.8 | 29.4 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
8.6 | 25.9 | GO:0045660 | positive regulation of neutrophil differentiation(GO:0045660) |
8.1 | 32.6 | GO:0070488 | neutrophil aggregation(GO:0070488) |
8.0 | 24.1 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
8.0 | 8.0 | GO:0035666 | TRIF-dependent toll-like receptor signaling pathway(GO:0035666) |
6.7 | 13.4 | GO:2000449 | regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
6.6 | 19.8 | GO:2000412 | positive regulation of thymocyte migration(GO:2000412) |
5.9 | 47.2 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
5.7 | 5.7 | GO:0033624 | negative regulation of integrin activation(GO:0033624) |
5.5 | 5.5 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) |
5.4 | 48.3 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
4.8 | 9.7 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
4.7 | 14.2 | GO:0014805 | smooth muscle adaptation(GO:0014805) |
4.7 | 42.7 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
4.7 | 14.0 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
4.6 | 18.6 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
4.5 | 13.4 | GO:2001200 | positive regulation of dendritic cell differentiation(GO:2001200) |
4.4 | 17.4 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
4.1 | 16.2 | GO:0044010 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
4.0 | 36.3 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
3.9 | 19.7 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
3.9 | 7.8 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
3.9 | 19.5 | GO:1904171 | negative regulation of bleb assembly(GO:1904171) |
3.9 | 11.7 | GO:0002305 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
3.8 | 3.8 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
3.8 | 11.4 | GO:0002343 | peripheral B cell selection(GO:0002343) B cell affinity maturation(GO:0002344) |
3.7 | 78.1 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
3.5 | 10.6 | GO:1903969 | regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) regulation of response to macrophage colony-stimulating factor(GO:1903969) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) |
3.5 | 17.5 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
3.5 | 6.9 | GO:0045575 | basophil activation(GO:0045575) |
3.4 | 10.2 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
3.3 | 10.0 | GO:0002215 | defense response to nematode(GO:0002215) |
3.3 | 10.0 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) positive regulation of cytolysis in other organism(GO:0051714) |
3.3 | 9.9 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
3.2 | 9.7 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
3.2 | 25.8 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
3.1 | 6.2 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
3.1 | 24.6 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
3.1 | 6.1 | GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
3.0 | 27.3 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
3.0 | 18.1 | GO:0006116 | NADH oxidation(GO:0006116) |
2.9 | 17.5 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
2.9 | 8.6 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
2.8 | 37.0 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
2.8 | 11.2 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
2.8 | 13.9 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
2.8 | 11.1 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
2.8 | 13.8 | GO:0032831 | positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
2.8 | 13.8 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
2.7 | 8.1 | GO:0032701 | negative regulation of granulocyte macrophage colony-stimulating factor production(GO:0032685) negative regulation of interleukin-18 production(GO:0032701) |
2.7 | 8.1 | GO:0021570 | rhombomere 4 development(GO:0021570) |
2.7 | 23.9 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
2.7 | 13.3 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
2.6 | 21.2 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
2.6 | 7.9 | GO:0002543 | activation of blood coagulation via clotting cascade(GO:0002543) phosphatidylserine exposure on blood platelet(GO:0097045) |
2.6 | 23.6 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
2.6 | 39.1 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
2.6 | 10.4 | GO:0071725 | response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
2.6 | 12.9 | GO:0006742 | NADP catabolic process(GO:0006742) |
2.6 | 23.1 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
2.5 | 7.5 | GO:0090320 | regulation of chylomicron remnant clearance(GO:0090320) |
2.5 | 14.9 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
2.4 | 21.8 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
2.4 | 7.2 | GO:0035702 | monocyte homeostasis(GO:0035702) |
2.3 | 30.3 | GO:0001771 | immunological synapse formation(GO:0001771) |
2.3 | 48.4 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
2.3 | 6.9 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
2.3 | 11.3 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
2.2 | 6.7 | GO:0072299 | negative regulation of metanephric glomerulus development(GO:0072299) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
2.2 | 11.0 | GO:0002352 | B cell negative selection(GO:0002352) |
2.2 | 19.8 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
2.2 | 12.9 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
2.2 | 10.8 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
2.1 | 6.3 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) nucleoside transmembrane transport(GO:1901642) |
2.1 | 43.9 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
2.1 | 6.3 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
2.1 | 10.4 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
2.0 | 26.5 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
2.0 | 14.2 | GO:0072619 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
2.0 | 6.0 | GO:1904093 | regulation of autophagic cell death(GO:1904092) negative regulation of autophagic cell death(GO:1904093) |
2.0 | 6.0 | GO:0036388 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) DNA replication preinitiation complex assembly(GO:0071163) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
2.0 | 7.9 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
2.0 | 19.6 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
1.9 | 1.9 | GO:2000317 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
1.9 | 9.6 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
1.9 | 7.6 | GO:0045659 | negative regulation of neutrophil differentiation(GO:0045659) |
1.9 | 3.8 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
1.9 | 13.2 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
1.9 | 5.6 | GO:0010925 | regulation of inositol-polyphosphate 5-phosphatase activity(GO:0010924) positive regulation of inositol-polyphosphate 5-phosphatase activity(GO:0010925) phospholipase C-inhibiting G-protein coupled receptor signaling pathway(GO:0030845) regulation of cell diameter(GO:0060305) |
1.9 | 5.6 | GO:0033082 | regulation of extrathymic T cell differentiation(GO:0033082) |
1.9 | 3.7 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
1.8 | 5.5 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
1.8 | 7.3 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) |
1.8 | 67.0 | GO:0045730 | respiratory burst(GO:0045730) |
1.8 | 7.2 | GO:1904569 | regulation of selenocysteine incorporation(GO:1904569) |
1.8 | 14.4 | GO:0045076 | regulation of interleukin-2 biosynthetic process(GO:0045076) |
1.8 | 5.4 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
1.8 | 3.6 | GO:0010957 | negative regulation of vitamin D biosynthetic process(GO:0010957) |
1.8 | 5.4 | GO:2000349 | regulation of granuloma formation(GO:0002631) negative regulation of granuloma formation(GO:0002632) regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) negative regulation of CD40 signaling pathway(GO:2000349) |
1.8 | 8.9 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
1.8 | 14.1 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
1.8 | 5.3 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
1.7 | 3.5 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
1.7 | 5.2 | GO:1904826 | regulation of hydrogen sulfide biosynthetic process(GO:1904826) positive regulation of hydrogen sulfide biosynthetic process(GO:1904828) |
1.7 | 3.5 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
1.7 | 6.9 | GO:0017126 | nucleologenesis(GO:0017126) |
1.7 | 6.9 | GO:1904209 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
1.7 | 6.8 | GO:0032298 | positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
1.7 | 5.1 | GO:1904975 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
1.7 | 13.3 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
1.7 | 6.6 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
1.6 | 6.6 | GO:0072355 | histone H3-T3 phosphorylation(GO:0072355) |
1.6 | 50.9 | GO:0008053 | mitochondrial fusion(GO:0008053) |
1.6 | 9.8 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
1.6 | 8.1 | GO:0060057 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
1.6 | 20.9 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
1.6 | 4.8 | GO:0071626 | thorax and anterior abdomen determination(GO:0007356) mastication(GO:0071626) learned vocalization behavior(GO:0098583) |
1.6 | 3.1 | GO:0032690 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
1.6 | 3.1 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
1.6 | 7.8 | GO:0031392 | regulation of prostaglandin biosynthetic process(GO:0031392) positive regulation of prostaglandin biosynthetic process(GO:0031394) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
1.6 | 6.2 | GO:0002030 | inhibitory G-protein coupled receptor phosphorylation(GO:0002030) |
1.5 | 15.4 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
1.5 | 6.1 | GO:0016068 | regulation of type I hypersensitivity(GO:0001810) positive regulation of type I hypersensitivity(GO:0001812) type I hypersensitivity(GO:0016068) |
1.5 | 9.2 | GO:0071918 | urea transmembrane transport(GO:0071918) |
1.5 | 4.6 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
1.5 | 3.0 | GO:0036301 | macrophage colony-stimulating factor production(GO:0036301) granulocyte colony-stimulating factor production(GO:0071611) regulation of granulocyte colony-stimulating factor production(GO:0071655) regulation of macrophage colony-stimulating factor production(GO:1901256) |
1.5 | 6.0 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
1.5 | 3.0 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
1.5 | 4.4 | GO:0048611 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
1.4 | 12.9 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
1.4 | 7.2 | GO:0048539 | bone marrow development(GO:0048539) |
1.4 | 10.0 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
1.4 | 5.7 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
1.4 | 22.5 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
1.4 | 2.8 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
1.4 | 4.1 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
1.4 | 6.8 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
1.4 | 12.2 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
1.4 | 25.7 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
1.4 | 6.8 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
1.3 | 4.0 | GO:1903632 | positive regulation of aminoacyl-tRNA ligase activity(GO:1903632) |
1.3 | 5.4 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) leading strand elongation(GO:0006272) |
1.3 | 6.7 | GO:0002432 | granuloma formation(GO:0002432) |
1.3 | 4.0 | GO:0043369 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment(GO:0043369) |
1.3 | 4.0 | GO:0010138 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) pyrimidine ribonucleotide salvage(GO:0010138) pyrimidine nucleotide salvage(GO:0032262) UMP salvage(GO:0044206) CMP metabolic process(GO:0046035) |
1.3 | 9.3 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
1.3 | 15.9 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
1.3 | 3.9 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
1.3 | 2.6 | GO:1905064 | negative regulation of vascular smooth muscle cell differentiation(GO:1905064) |
1.3 | 2.6 | GO:0072718 | response to cisplatin(GO:0072718) |
1.3 | 2.6 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
1.3 | 3.9 | GO:0071608 | macrophage inflammatory protein-1 alpha production(GO:0071608) regulation of macrophage inflammatory protein 1 alpha production(GO:0071640) |
1.3 | 23.1 | GO:0032733 | positive regulation of interleukin-10 production(GO:0032733) |
1.3 | 15.4 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
1.3 | 14.0 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
1.2 | 2.5 | GO:1902568 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
1.2 | 5.0 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
1.2 | 6.2 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
1.2 | 41.0 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
1.2 | 1.2 | GO:0001788 | antibody-dependent cellular cytotoxicity(GO:0001788) |
1.2 | 14.9 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
1.2 | 6.1 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
1.2 | 3.7 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
1.2 | 4.9 | GO:0009609 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
1.2 | 3.6 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
1.2 | 1.2 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
1.2 | 3.6 | GO:1904155 | DN2 thymocyte differentiation(GO:1904155) DN3 thymocyte differentiation(GO:1904156) |
1.2 | 1.2 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
1.2 | 3.6 | GO:0034769 | basement membrane disassembly(GO:0034769) |
1.2 | 10.8 | GO:0040009 | regulation of growth rate(GO:0040009) |
1.2 | 4.8 | GO:0009814 | defense response, incompatible interaction(GO:0009814) defense response to bacterium, incompatible interaction(GO:0009816) regulation of defense response to bacterium, incompatible interaction(GO:1902477) |
1.2 | 8.4 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
1.2 | 3.6 | GO:2000813 | negative regulation of barbed-end actin filament capping(GO:2000813) |
1.2 | 14.2 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
1.2 | 3.6 | GO:2000256 | thrombopoietin-mediated signaling pathway(GO:0038163) positive regulation of male germ cell proliferation(GO:2000256) |
1.2 | 15.3 | GO:0002517 | T cell tolerance induction(GO:0002517) |
1.2 | 4.7 | GO:0009744 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
1.1 | 50.6 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
1.1 | 4.6 | GO:0051325 | interphase(GO:0051325) mitotic interphase(GO:0051329) |
1.1 | 3.4 | GO:0072347 | response to anesthetic(GO:0072347) |
1.1 | 3.4 | GO:1904444 | positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) regulation of voltage-gated chloride channel activity(GO:1902941) positive regulation of voltage-gated chloride channel activity(GO:1902943) regulation of establishment of Sertoli cell barrier(GO:1904444) positive regulation of establishment of Sertoli cell barrier(GO:1904446) negative regulation of type B pancreatic cell development(GO:2000077) |
1.1 | 5.7 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
1.1 | 14.6 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
1.1 | 5.6 | GO:0002360 | T cell lineage commitment(GO:0002360) |
1.1 | 7.8 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
1.1 | 18.8 | GO:0072606 | interleukin-8 secretion(GO:0072606) |
1.1 | 13.2 | GO:0071493 | cellular response to UV-B(GO:0071493) |
1.1 | 7.7 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
1.1 | 2.2 | GO:0090135 | actin filament branching(GO:0090135) |
1.1 | 3.3 | GO:1904116 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
1.1 | 9.8 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
1.1 | 19.4 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
1.1 | 3.2 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
1.1 | 11.9 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
1.1 | 8.6 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
1.1 | 3.2 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
1.1 | 3.2 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
1.1 | 7.4 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
1.1 | 4.2 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
1.1 | 13.7 | GO:0071361 | cellular response to ethanol(GO:0071361) |
1.1 | 20.1 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
1.0 | 3.1 | GO:0036275 | response to 5-fluorouracil(GO:0036275) |
1.0 | 5.2 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
1.0 | 11.5 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
1.0 | 3.1 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
1.0 | 4.1 | GO:0032650 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) regulation of interleukin-1 alpha secretion(GO:0050705) positive regulation of interleukin-1 alpha secretion(GO:0050717) |
1.0 | 1.0 | GO:2001107 | negative regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001107) |
1.0 | 10.3 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
1.0 | 6.1 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
1.0 | 2.0 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
1.0 | 2.0 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
1.0 | 11.2 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
1.0 | 35.3 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
1.0 | 1.0 | GO:0032667 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
1.0 | 3.0 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
1.0 | 14.1 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
1.0 | 23.0 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
1.0 | 3.0 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
1.0 | 18.0 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) |
1.0 | 2.0 | GO:0070425 | negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
1.0 | 4.9 | GO:0072672 | neutrophil extravasation(GO:0072672) |
1.0 | 4.9 | GO:0032604 | granulocyte macrophage colony-stimulating factor production(GO:0032604) regulation of granulocyte macrophage colony-stimulating factor production(GO:0032645) positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
1.0 | 1.0 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
1.0 | 5.9 | GO:0097531 | mast cell chemotaxis(GO:0002551) mast cell migration(GO:0097531) |
1.0 | 5.9 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
1.0 | 1.0 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
1.0 | 3.9 | GO:0060709 | glycogen cell differentiation involved in embryonic placenta development(GO:0060709) |
1.0 | 1.0 | GO:0010652 | atrial ventricular junction remodeling(GO:0003294) regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
0.9 | 0.9 | GO:0060702 | negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) |
0.9 | 9.5 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.9 | 5.7 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.9 | 4.7 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.9 | 0.9 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.9 | 15.0 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) |
0.9 | 3.7 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
0.9 | 9.2 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.9 | 58.7 | GO:0045576 | mast cell activation(GO:0045576) |
0.9 | 3.7 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
0.9 | 7.2 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
0.9 | 3.6 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
0.9 | 13.4 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.9 | 15.0 | GO:0072676 | lymphocyte migration(GO:0072676) |
0.9 | 15.7 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
0.9 | 15.6 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.9 | 2.6 | GO:0070175 | positive regulation of enamel mineralization(GO:0070175) |
0.9 | 12.1 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.9 | 2.6 | GO:0097184 | amiloride transport(GO:0015898) cellular response to copper ion starvation(GO:0035874) response to azide(GO:0097184) cellular response to azide(GO:0097185) |
0.8 | 7.6 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
0.8 | 4.2 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
0.8 | 5.9 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.8 | 5.9 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
0.8 | 1.7 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.8 | 10.8 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.8 | 2.5 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.8 | 4.9 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.8 | 0.8 | GO:2000642 | negative regulation of early endosome to late endosome transport(GO:2000642) |
0.8 | 13.1 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.8 | 3.2 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.8 | 0.8 | GO:1902462 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
0.8 | 0.8 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
0.8 | 6.4 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.8 | 2.4 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.8 | 3.9 | GO:0030576 | Cajal body organization(GO:0030576) |
0.8 | 2.4 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.8 | 1.6 | GO:0051454 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.8 | 19.5 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.8 | 9.3 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.8 | 8.4 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.8 | 3.8 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.8 | 40.2 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.8 | 2.3 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.7 | 3.0 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
0.7 | 0.7 | GO:0060032 | notochord regression(GO:0060032) |
0.7 | 0.7 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.7 | 2.2 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.7 | 0.7 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.7 | 2.2 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.7 | 2.9 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.7 | 4.4 | GO:0001757 | somite specification(GO:0001757) |
0.7 | 15.3 | GO:0051639 | actin filament network formation(GO:0051639) |
0.7 | 24.8 | GO:0097320 | membrane tubulation(GO:0097320) |
0.7 | 4.3 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.7 | 2.2 | GO:0018160 | peptidyl-pyrromethane cofactor linkage(GO:0018160) |
0.7 | 9.2 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.7 | 2.8 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
0.7 | 3.5 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.7 | 13.2 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.7 | 1.4 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.7 | 3.5 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.7 | 0.7 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.7 | 2.7 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.7 | 3.4 | GO:0048478 | replication fork protection(GO:0048478) |
0.7 | 2.0 | GO:0042119 | neutrophil activation(GO:0042119) |
0.7 | 1.4 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
0.7 | 6.8 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.7 | 3.4 | GO:0060022 | hard palate development(GO:0060022) |
0.7 | 8.8 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.7 | 6.1 | GO:0040031 | snRNA modification(GO:0040031) |
0.7 | 29.7 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.7 | 2.0 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.7 | 6.1 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.7 | 2.7 | GO:0007522 | visceral muscle development(GO:0007522) |
0.7 | 2.7 | GO:0043696 | dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
0.7 | 3.3 | GO:1902732 | positive regulation of chondrocyte proliferation(GO:1902732) |
0.7 | 38.3 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.7 | 18.5 | GO:0006491 | N-glycan processing(GO:0006491) |
0.7 | 3.3 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.7 | 2.6 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.6 | 2.6 | GO:0040030 | regulation of molecular function, epigenetic(GO:0040030) |
0.6 | 3.9 | GO:0052490 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.6 | 8.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.6 | 1.9 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
0.6 | 6.4 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.6 | 3.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.6 | 4.4 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.6 | 2.5 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.6 | 5.6 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.6 | 1.2 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.6 | 4.9 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.6 | 2.5 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.6 | 2.5 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.6 | 1.8 | GO:2000832 | negative regulation of steroid hormone secretion(GO:2000832) |
0.6 | 1.8 | GO:0007225 | patched ligand maturation(GO:0007225) signal maturation(GO:0035638) |
0.6 | 2.4 | GO:0019323 | pentose catabolic process(GO:0019323) |
0.6 | 1.8 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
0.6 | 4.9 | GO:0097646 | dimeric G-protein coupled receptor signaling pathway(GO:0038042) calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.6 | 10.9 | GO:0050832 | defense response to fungus(GO:0050832) |
0.6 | 9.7 | GO:0031295 | T cell costimulation(GO:0031295) |
0.6 | 2.4 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.6 | 3.0 | GO:0000432 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
0.6 | 6.0 | GO:0008228 | opsonization(GO:0008228) |
0.6 | 3.0 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.6 | 4.8 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
0.6 | 1.2 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.6 | 3.0 | GO:0060099 | regulation of phagocytosis, engulfment(GO:0060099) |
0.6 | 1.8 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.6 | 1.2 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.6 | 4.7 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.6 | 2.3 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.6 | 2.9 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
0.6 | 1.2 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
0.6 | 1.2 | GO:0048069 | eye pigmentation(GO:0048069) |
0.6 | 1.7 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.6 | 7.0 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.6 | 1.7 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
0.6 | 4.6 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) |
0.6 | 12.7 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.6 | 4.0 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
0.6 | 2.3 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
0.6 | 17.0 | GO:0030033 | microvillus assembly(GO:0030033) |
0.6 | 2.3 | GO:0002507 | tolerance induction(GO:0002507) |
0.6 | 7.4 | GO:0002717 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.6 | 1.7 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) |
0.6 | 14.0 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.6 | 12.3 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.6 | 2.8 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.6 | 22.4 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.6 | 6.1 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.6 | 2.2 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.6 | 7.2 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.6 | 6.1 | GO:0015074 | DNA integration(GO:0015074) |
0.6 | 3.3 | GO:0042891 | antibiotic transport(GO:0042891) |
0.5 | 0.5 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.5 | 3.3 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.5 | 1.6 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
0.5 | 2.2 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.5 | 3.8 | GO:0032570 | response to progesterone(GO:0032570) |
0.5 | 2.7 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.5 | 14.4 | GO:0050798 | activated T cell proliferation(GO:0050798) |
0.5 | 2.7 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.5 | 4.8 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.5 | 1.6 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.5 | 4.2 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.5 | 3.1 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.5 | 16.7 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.5 | 3.1 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.5 | 1.6 | GO:0021759 | globus pallidus development(GO:0021759) |
0.5 | 3.1 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.5 | 11.9 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.5 | 12.3 | GO:0000303 | response to superoxide(GO:0000303) |
0.5 | 2.6 | GO:1901228 | positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
0.5 | 4.6 | GO:0019886 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.5 | 4.1 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.5 | 6.6 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.5 | 2.5 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.5 | 1.5 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.5 | 1.5 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.5 | 2.0 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.5 | 4.0 | GO:0071802 | cellular response to muramyl dipeptide(GO:0071225) negative regulation of podosome assembly(GO:0071802) |
0.5 | 1.5 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) basophil differentiation(GO:0030221) eosinophil fate commitment(GO:0035854) |
0.5 | 6.0 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.5 | 8.0 | GO:0043485 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.5 | 2.0 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.5 | 1.0 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.5 | 3.0 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.5 | 3.5 | GO:0007527 | adult somatic muscle development(GO:0007527) |
0.5 | 2.5 | GO:2000584 | regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
0.5 | 5.4 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.5 | 3.0 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.5 | 2.5 | GO:1903756 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.5 | 7.8 | GO:0098751 | bone cell development(GO:0098751) |
0.5 | 2.9 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.5 | 4.9 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.5 | 1.5 | GO:0031590 | wybutosine metabolic process(GO:0031590) wybutosine biosynthetic process(GO:0031591) |
0.5 | 0.5 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.5 | 6.3 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.5 | 1.0 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.5 | 3.8 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.5 | 1.0 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.5 | 1.9 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.5 | 0.5 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
0.5 | 2.4 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
0.5 | 1.4 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.5 | 1.9 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.5 | 0.9 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
0.5 | 8.0 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.5 | 2.8 | GO:0001980 | regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
0.5 | 2.3 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.5 | 2.8 | GO:0032530 | regulation of microvillus organization(GO:0032530) |
0.5 | 3.7 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.5 | 7.0 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.5 | 3.7 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.5 | 4.1 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.5 | 1.4 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.5 | 2.3 | GO:0015867 | ATP transport(GO:0015867) |
0.5 | 3.6 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.5 | 0.9 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.5 | 2.7 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.5 | 2.7 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.4 | 14.4 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.4 | 3.1 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.4 | 1.3 | GO:0000451 | rRNA 2'-O-methylation(GO:0000451) |
0.4 | 22.2 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.4 | 3.6 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.4 | 2.2 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.4 | 8.4 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.4 | 2.2 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.4 | 4.4 | GO:0032264 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
0.4 | 2.2 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.4 | 1.3 | GO:0021508 | floor plate formation(GO:0021508) floor plate morphogenesis(GO:0033505) |
0.4 | 4.3 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.4 | 6.9 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.4 | 9.8 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.4 | 65.5 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.4 | 0.8 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.4 | 0.8 | GO:2000435 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
0.4 | 6.8 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.4 | 1.7 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.4 | 61.3 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.4 | 1.3 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.4 | 1.3 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.4 | 1.7 | GO:0071586 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
0.4 | 6.7 | GO:0051014 | actin filament severing(GO:0051014) |
0.4 | 4.2 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.4 | 2.1 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.4 | 1.7 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.4 | 2.9 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.4 | 1.6 | GO:0016062 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
0.4 | 1.2 | GO:0021852 | pyramidal neuron migration(GO:0021852) |
0.4 | 8.2 | GO:0002228 | natural killer cell mediated immunity(GO:0002228) |
0.4 | 25.2 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.4 | 2.0 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.4 | 1.6 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.4 | 0.4 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.4 | 2.4 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.4 | 2.4 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.4 | 1.6 | GO:0061188 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
0.4 | 1.6 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.4 | 3.1 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.4 | 4.7 | GO:0048242 | epinephrine secretion(GO:0048242) |
0.4 | 3.5 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.4 | 1.5 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.4 | 3.8 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.4 | 10.3 | GO:0043620 | regulation of DNA-templated transcription in response to stress(GO:0043620) |
0.4 | 2.3 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.4 | 1.9 | GO:0044727 | DNA demethylation of male pronucleus(GO:0044727) |
0.4 | 6.0 | GO:0097435 | fibril organization(GO:0097435) |
0.4 | 2.2 | GO:1901315 | negative regulation of histone ubiquitination(GO:0033183) histone H2A K63-linked ubiquitination(GO:0070535) regulation of protein K63-linked ubiquitination(GO:1900044) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
0.4 | 5.6 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.4 | 1.8 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.4 | 2.9 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.4 | 4.0 | GO:0072189 | ureter development(GO:0072189) |
0.4 | 4.0 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.4 | 0.7 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.4 | 1.4 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.4 | 2.5 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.4 | 4.9 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.4 | 12.6 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.3 | 2.1 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.3 | 16.3 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.3 | 5.1 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.3 | 1.0 | GO:0009624 | response to nematode(GO:0009624) |
0.3 | 3.4 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.3 | 0.3 | GO:1990009 | retinal cell apoptotic process(GO:1990009) |
0.3 | 9.9 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.3 | 2.0 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.3 | 1.0 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.3 | 4.3 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.3 | 1.3 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.3 | 3.2 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.3 | 1.0 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.3 | 0.6 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.3 | 1.0 | GO:0097476 | spinal cord motor neuron migration(GO:0097476) |
0.3 | 0.3 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.3 | 1.0 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.3 | 18.4 | GO:0070527 | platelet aggregation(GO:0070527) |
0.3 | 0.9 | GO:0098976 | excitatory chemical synaptic transmission(GO:0098976) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.3 | 7.0 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.3 | 6.6 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.3 | 1.9 | GO:0016266 | O-glycan processing(GO:0016266) |
0.3 | 3.1 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.3 | 9.4 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.3 | 2.8 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.3 | 1.2 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.3 | 1.9 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
0.3 | 1.2 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.3 | 1.2 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
0.3 | 21.2 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
0.3 | 3.1 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.3 | 1.8 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.3 | 3.0 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.3 | 1.8 | GO:2001028 | positive regulation of endothelial cell chemotaxis(GO:2001028) |
0.3 | 1.5 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
0.3 | 3.3 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.3 | 0.9 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.3 | 4.5 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.3 | 6.0 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.3 | 2.4 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.3 | 1.8 | GO:0010166 | ether lipid biosynthetic process(GO:0008611) wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.3 | 4.2 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.3 | 1.5 | GO:0060023 | soft palate development(GO:0060023) |
0.3 | 2.0 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.3 | 1.7 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.3 | 1.4 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.3 | 0.6 | GO:2000589 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) cell migration involved in metanephros development(GO:0035788) metanephric mesenchymal cell migration(GO:0035789) positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) regulation of metanephric mesenchymal cell migration(GO:2000589) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.3 | 2.9 | GO:0032275 | luteinizing hormone secretion(GO:0032275) |
0.3 | 2.0 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) positive regulation of adherens junction organization(GO:1903393) |
0.3 | 5.4 | GO:0006907 | pinocytosis(GO:0006907) |
0.3 | 1.7 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.3 | 3.1 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.3 | 1.1 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.3 | 5.6 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.3 | 1.4 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.3 | 1.7 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.3 | 1.9 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) |
0.3 | 1.6 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
0.3 | 0.8 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
0.3 | 4.4 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) |
0.3 | 0.5 | GO:0033128 | negative regulation of histone phosphorylation(GO:0033128) |
0.3 | 0.8 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.3 | 10.4 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.3 | 1.1 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
0.3 | 7.5 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
0.3 | 2.4 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.3 | 2.6 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.3 | 3.4 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.3 | 1.8 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.3 | 1.3 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.3 | 4.7 | GO:0031000 | response to caffeine(GO:0031000) |
0.3 | 1.8 | GO:1900170 | negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
0.3 | 1.8 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.3 | 4.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.3 | 1.3 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.3 | 7.1 | GO:0006284 | base-excision repair(GO:0006284) |
0.3 | 3.6 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.3 | 2.8 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.3 | 4.0 | GO:0051601 | exocyst localization(GO:0051601) |
0.3 | 3.0 | GO:0030168 | platelet activation(GO:0030168) |
0.3 | 5.3 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.2 | 1.0 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.2 | 2.7 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.2 | 1.5 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.2 | 0.5 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.2 | 0.5 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.2 | 0.7 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.2 | 3.1 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.2 | 1.7 | GO:0090009 | primitive streak formation(GO:0090009) |
0.2 | 1.9 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.2 | 3.5 | GO:1990090 | response to nerve growth factor(GO:1990089) cellular response to nerve growth factor stimulus(GO:1990090) |
0.2 | 0.9 | GO:0090472 | dibasic protein processing(GO:0090472) |
0.2 | 8.8 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.2 | 2.1 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.2 | 7.4 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.2 | 8.7 | GO:0030834 | regulation of actin filament depolymerization(GO:0030834) |
0.2 | 0.9 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
0.2 | 2.3 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.2 | 3.1 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.2 | 1.3 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.2 | 5.8 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.2 | 3.1 | GO:0080009 | mRNA methylation(GO:0080009) |
0.2 | 1.1 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.2 | 1.1 | GO:1902167 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902167) |
0.2 | 2.2 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.2 | 1.8 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.2 | 4.6 | GO:0035411 | catenin import into nucleus(GO:0035411) |
0.2 | 6.9 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.2 | 2.8 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.2 | 1.3 | GO:0015889 | cobalamin transport(GO:0015889) |
0.2 | 0.9 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.2 | 0.8 | GO:0048254 | snoRNA localization(GO:0048254) |
0.2 | 0.8 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.2 | 5.3 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.2 | 0.8 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.2 | 1.7 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.2 | 1.0 | GO:0051096 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.2 | 2.3 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
0.2 | 0.6 | GO:0051030 | snRNA transport(GO:0051030) |
0.2 | 1.4 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.2 | 2.0 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.2 | 3.4 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.2 | 0.8 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.2 | 0.4 | GO:0097503 | sialylation(GO:0097503) |
0.2 | 5.6 | GO:2000737 | negative regulation of stem cell differentiation(GO:2000737) |
0.2 | 1.6 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.2 | 1.6 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.2 | 4.0 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.2 | 0.6 | GO:1901994 | negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.2 | 3.0 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.2 | 0.6 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.2 | 1.4 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.2 | 2.3 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.2 | 0.6 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.2 | 2.1 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.2 | 0.8 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.2 | 2.5 | GO:0032060 | bleb assembly(GO:0032060) |
0.2 | 1.9 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.2 | 1.1 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.2 | 0.9 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.2 | 12.4 | GO:0042113 | B cell activation(GO:0042113) |
0.2 | 1.1 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.2 | 1.5 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.2 | 0.2 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.2 | 4.0 | GO:0070542 | response to fatty acid(GO:0070542) |
0.2 | 0.7 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
0.2 | 6.8 | GO:0050715 | positive regulation of cytokine secretion(GO:0050715) |
0.2 | 2.5 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.2 | 1.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.2 | 0.9 | GO:0003409 | optic cup structural organization(GO:0003409) |
0.2 | 0.5 | GO:0060618 | nipple development(GO:0060618) |
0.2 | 0.5 | GO:0034970 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) histone H3-R2 methylation(GO:0034970) |
0.2 | 3.7 | GO:0048255 | mRNA stabilization(GO:0048255) |
0.2 | 0.5 | GO:0038156 | interleukin-3-mediated signaling pathway(GO:0038156) |
0.2 | 1.5 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.2 | 0.6 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.2 | 3.2 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.2 | 6.4 | GO:0035904 | aorta development(GO:0035904) |
0.2 | 5.4 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.2 | 2.1 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.2 | 2.2 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.2 | 0.9 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.2 | 0.9 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.2 | 0.5 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.2 | 1.4 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.2 | 1.1 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.2 | 3.8 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.2 | 1.2 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.1 | 0.9 | GO:1902914 | regulation of protein polyubiquitination(GO:1902914) |
0.1 | 1.2 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.1 | 0.1 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.1 | 0.9 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.1 | 0.9 | GO:1902624 | positive regulation of neutrophil migration(GO:1902624) |
0.1 | 1.9 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.1 | 1.1 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.1 | 0.4 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.1 | 0.7 | GO:0098957 | anterograde axonal transport of mitochondrion(GO:0098957) |
0.1 | 0.7 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
0.1 | 0.7 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.1 | 1.7 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.1 | 0.8 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 2.6 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.7 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.8 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.1 | 1.7 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 1.5 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) histone H4-K12 acetylation(GO:0043983) |
0.1 | 14.3 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.1 | 0.4 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.1 | 5.2 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 0.5 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
0.1 | 0.7 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.1 | 1.6 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 1.4 | GO:0098719 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 2.1 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.3 | GO:1990180 | mitochondrial tRNA 3'-end processing(GO:1990180) |
0.1 | 0.4 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.1 | 0.5 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.1 | 0.7 | GO:0043278 | response to morphine(GO:0043278) |
0.1 | 0.9 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 0.9 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.1 | 0.7 | GO:0031054 | pre-miRNA processing(GO:0031054) |
0.1 | 3.0 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.1 | 2.5 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.1 | 1.6 | GO:0032288 | myelin assembly(GO:0032288) |
0.1 | 1.5 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.1 | 1.6 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.7 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 4.0 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.1 | 1.1 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.1 | 0.1 | GO:2001212 | regulation of vasculogenesis(GO:2001212) positive regulation of vasculogenesis(GO:2001214) |
0.1 | 0.6 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.1 | 2.2 | GO:0051923 | sulfation(GO:0051923) |
0.1 | 0.3 | GO:1990839 | response to endothelin(GO:1990839) |
0.1 | 0.6 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.1 | 1.1 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.1 | 2.6 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.9 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.1 | 1.8 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.1 | 0.8 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.1 | 0.6 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 2.9 | GO:0046632 | alpha-beta T cell differentiation(GO:0046632) |
0.1 | 6.2 | GO:0006304 | DNA modification(GO:0006304) |
0.1 | 2.3 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.1 | 0.8 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.1 | 0.5 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.1 | 2.6 | GO:0046677 | response to antibiotic(GO:0046677) |
0.1 | 0.6 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.1 | 0.7 | GO:2000352 | negative regulation of endothelial cell apoptotic process(GO:2000352) |
0.1 | 0.8 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.1 | 0.4 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.1 | 0.5 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.1 | 3.3 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) |
0.1 | 0.9 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 1.6 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.1 | 0.7 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 2.6 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 0.8 | GO:0043545 | molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.4 | GO:0008355 | olfactory learning(GO:0008355) |
0.1 | 0.4 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.2 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.1 | 0.8 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.1 | 0.3 | GO:0072710 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.1 | 2.4 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 0.2 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.1 | 1.6 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.1 | 3.6 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.1 | 1.0 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 1.8 | GO:0043276 | anoikis(GO:0043276) |
0.1 | 1.5 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.6 | GO:0051012 | microtubule sliding(GO:0051012) |
0.1 | 4.4 | GO:0030833 | regulation of actin filament polymerization(GO:0030833) |
0.1 | 0.7 | GO:0019985 | translesion synthesis(GO:0019985) |
0.1 | 1.1 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 0.8 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.1 | 0.8 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.3 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.1 | 0.7 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.1 | 1.0 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.1 | 0.3 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.1 | 0.9 | GO:0007099 | centriole replication(GO:0007099) |
0.1 | 2.0 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.1 | 2.9 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.1 | 0.1 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.1 | 1.1 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.1 | 1.9 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.1 | 0.2 | GO:0045212 | neurotransmitter receptor biosynthetic process(GO:0045212) |
0.1 | 0.2 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.1 | 0.4 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.1 | 0.6 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.4 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.1 | 0.9 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.1 | 0.2 | GO:0006713 | glucocorticoid catabolic process(GO:0006713) |
0.1 | 0.3 | GO:0010165 | response to X-ray(GO:0010165) |
0.1 | 0.2 | GO:0021633 | optic nerve structural organization(GO:0021633) |
0.1 | 0.2 | GO:0046038 | GMP catabolic process(GO:0046038) |
0.1 | 0.2 | GO:0043096 | adenine salvage(GO:0006168) purine nucleobase salvage(GO:0043096) adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.1 | 2.6 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
0.1 | 0.6 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 1.0 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.1 | 1.2 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.1 | 0.3 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.0 | 0.3 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.0 | 0.4 | GO:0034434 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.0 | 0.7 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.6 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.0 | 2.7 | GO:0000910 | cytokinesis(GO:0000910) |
0.0 | 0.1 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) protein K33-linked deubiquitination(GO:1990168) |
0.0 | 2.4 | GO:0030217 | T cell differentiation(GO:0030217) |
0.0 | 0.2 | GO:0072738 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) cellular response to sodium arsenite(GO:1903936) |
0.0 | 0.9 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.2 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.0 | 0.2 | GO:0070164 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) negative regulation of adiponectin secretion(GO:0070164) |
0.0 | 0.4 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.0 | 0.1 | GO:0046333 | octopamine biosynthetic process(GO:0006589) octopamine metabolic process(GO:0046333) |
0.0 | 0.4 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.0 | 0.2 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.0 | 0.3 | GO:0018195 | peptidyl-arginine modification(GO:0018195) |
0.0 | 1.0 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.0 | 0.2 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.0 | 0.3 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.6 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.0 | 0.2 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.0 | 0.2 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.0 | 0.1 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.0 | 0.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.1 | GO:0090004 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.0 | 0.3 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.0 | 0.2 | GO:0002763 | positive regulation of myeloid leukocyte differentiation(GO:0002763) |
0.0 | 0.1 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.0 | 0.2 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.0 | 0.2 | GO:0090398 | cellular senescence(GO:0090398) |
0.0 | 0.1 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.1 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.0 | 0.1 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.0 | 0.3 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.0 | 0.1 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.0 | 0.6 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.0 | 0.1 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.0 | 0.2 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.0 | 1.2 | GO:0009267 | cellular response to starvation(GO:0009267) |
0.0 | 0.1 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.0 | 0.0 | GO:0034214 | protein hexamerization(GO:0034214) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.1 | 30.3 | GO:0036398 | TCR signalosome(GO:0036398) |
6.8 | 82.0 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
6.1 | 30.5 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
5.6 | 28.2 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
5.2 | 20.8 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
4.9 | 79.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
4.4 | 17.7 | GO:0032127 | dense core granule membrane(GO:0032127) |
3.9 | 38.7 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
3.6 | 14.3 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
3.1 | 12.3 | GO:0036284 | tubulobulbar complex(GO:0036284) |
3.1 | 24.6 | GO:0042101 | T cell receptor complex(GO:0042101) |
3.0 | 51.0 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
2.5 | 133.5 | GO:0001772 | immunological synapse(GO:0001772) |
2.5 | 12.4 | GO:0044194 | cytolytic granule(GO:0044194) |
2.5 | 14.8 | GO:0031262 | Ndc80 complex(GO:0031262) |
2.4 | 9.8 | GO:0071438 | invadopodium membrane(GO:0071438) |
2.3 | 11.6 | GO:0030690 | Noc1p-Noc2p complex(GO:0030690) |
2.3 | 23.2 | GO:0019815 | B cell receptor complex(GO:0019815) |
2.3 | 6.9 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
2.2 | 13.4 | GO:0097342 | ripoptosome(GO:0097342) |
2.1 | 6.4 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
2.1 | 10.6 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
2.1 | 8.2 | GO:0008623 | CHRAC(GO:0008623) |
2.0 | 12.0 | GO:0097149 | centralspindlin complex(GO:0097149) |
2.0 | 6.0 | GO:0005656 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
2.0 | 5.9 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
1.9 | 13.4 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
1.9 | 3.8 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
1.8 | 35.6 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
1.8 | 10.6 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
1.7 | 6.8 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
1.7 | 6.7 | GO:1990298 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
1.6 | 6.5 | GO:0005608 | laminin-3 complex(GO:0005608) |
1.5 | 4.6 | GO:0032997 | Fc receptor complex(GO:0032997) Fc-epsilon receptor I complex(GO:0032998) |
1.5 | 10.7 | GO:0072487 | MSL complex(GO:0072487) |
1.5 | 10.6 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
1.5 | 40.6 | GO:0001891 | phagocytic cup(GO:0001891) |
1.5 | 4.5 | GO:0005673 | transcription factor TFIIE complex(GO:0005673) |
1.5 | 5.8 | GO:0070820 | tertiary granule(GO:0070820) |
1.5 | 5.8 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
1.4 | 7.2 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
1.4 | 57.5 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
1.4 | 16.8 | GO:0008278 | cohesin complex(GO:0008278) |
1.4 | 6.8 | GO:0071953 | elastic fiber(GO:0071953) |
1.3 | 20.9 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
1.2 | 17.4 | GO:0016589 | NURF complex(GO:0016589) |
1.2 | 12.4 | GO:0033093 | Weibel-Palade body(GO:0033093) |
1.2 | 3.7 | GO:0000235 | astral microtubule(GO:0000235) |
1.2 | 12.3 | GO:1990462 | omegasome(GO:1990462) |
1.2 | 14.8 | GO:0042613 | MHC class II protein complex(GO:0042613) |
1.1 | 3.4 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
1.1 | 3.4 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
1.1 | 5.7 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
1.1 | 5.6 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
1.1 | 3.3 | GO:0034457 | Mpp10 complex(GO:0034457) |
1.1 | 3.3 | GO:0097144 | BAX complex(GO:0097144) |
1.1 | 11.8 | GO:0097208 | alveolar lamellar body(GO:0097208) |
1.1 | 3.2 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
1.0 | 3.1 | GO:0097132 | cyclin D2-CDK6 complex(GO:0097132) |
1.0 | 6.3 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
1.0 | 3.1 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
0.9 | 2.8 | GO:0070992 | translation initiation complex(GO:0070992) |
0.9 | 0.9 | GO:0000322 | storage vacuole(GO:0000322) |
0.9 | 4.4 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.9 | 3.5 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.9 | 13.0 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.9 | 32.7 | GO:0002102 | podosome(GO:0002102) |
0.9 | 2.6 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.8 | 3.3 | GO:0097443 | sorting endosome(GO:0097443) |
0.8 | 56.1 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.8 | 5.8 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.8 | 4.9 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.8 | 8.8 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.8 | 7.8 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.8 | 7.7 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.8 | 2.3 | GO:1990423 | RZZ complex(GO:1990423) |
0.7 | 9.6 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.7 | 3.6 | GO:0031251 | PAN complex(GO:0031251) |
0.7 | 49.4 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.7 | 369.0 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.7 | 3.5 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.7 | 8.9 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.7 | 3.4 | GO:0061673 | mitotic spindle astral microtubule(GO:0061673) |
0.7 | 2.0 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.7 | 4.0 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.7 | 2.0 | GO:0014801 | longitudinal sarcoplasmic reticulum(GO:0014801) |
0.7 | 2.0 | GO:0030056 | hemidesmosome(GO:0030056) |
0.7 | 4.6 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.7 | 2.0 | GO:0032783 | ELL-EAF complex(GO:0032783) |
0.6 | 7.8 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.6 | 52.5 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.6 | 11.4 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.6 | 1.3 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
0.6 | 1.9 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.6 | 3.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.6 | 6.8 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.6 | 3.7 | GO:0042629 | mast cell granule(GO:0042629) |
0.6 | 1.8 | GO:0016939 | kinesin II complex(GO:0016939) |
0.6 | 6.5 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.6 | 14.3 | GO:0031527 | filopodium membrane(GO:0031527) |
0.6 | 14.1 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.6 | 3.9 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.6 | 10.6 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.6 | 3.9 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
0.6 | 3.9 | GO:1990357 | terminal web(GO:1990357) |
0.5 | 8.8 | GO:0042555 | MCM complex(GO:0042555) |
0.5 | 1.6 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.5 | 3.2 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.5 | 1.6 | GO:0055087 | Ski complex(GO:0055087) |
0.5 | 2.1 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
0.5 | 2.1 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
0.5 | 2.0 | GO:0035061 | interchromatin granule(GO:0035061) |
0.5 | 2.0 | GO:0071942 | XPC complex(GO:0071942) |
0.5 | 1.5 | GO:0034455 | t-UTP complex(GO:0034455) |
0.5 | 21.9 | GO:0045095 | keratin filament(GO:0045095) |
0.5 | 4.4 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.5 | 16.0 | GO:0042588 | zymogen granule(GO:0042588) |
0.5 | 4.4 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.5 | 6.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.5 | 43.2 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.5 | 3.3 | GO:0036396 | MIS complex(GO:0036396) |
0.5 | 3.7 | GO:0042581 | specific granule(GO:0042581) |
0.5 | 2.3 | GO:0017177 | glucosidase II complex(GO:0017177) |
0.4 | 9.8 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.4 | 2.7 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.4 | 40.3 | GO:0005795 | Golgi stack(GO:0005795) |
0.4 | 15.9 | GO:0032040 | small-subunit processome(GO:0032040) |
0.4 | 52.8 | GO:0016605 | PML body(GO:0016605) |
0.4 | 5.5 | GO:0071203 | WASH complex(GO:0071203) |
0.4 | 23.3 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.4 | 1.3 | GO:0038045 | large latent transforming growth factor-beta complex(GO:0038045) |
0.4 | 5.0 | GO:0000801 | central element(GO:0000801) |
0.4 | 2.5 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.4 | 9.0 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.4 | 5.7 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.4 | 20.7 | GO:0005657 | replication fork(GO:0005657) |
0.4 | 6.0 | GO:0005915 | zonula adherens(GO:0005915) |
0.4 | 1.6 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.4 | 1.2 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.4 | 4.2 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.4 | 6.5 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.4 | 10.3 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.4 | 3.0 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.4 | 3.0 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.4 | 2.2 | GO:0097422 | tubular endosome(GO:0097422) |
0.4 | 5.5 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.4 | 1.5 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.4 | 4.3 | GO:0005687 | U4 snRNP(GO:0005687) |
0.4 | 13.9 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.4 | 10.3 | GO:0097225 | sperm midpiece(GO:0097225) |
0.4 | 1.1 | GO:0043291 | RAVE complex(GO:0043291) |
0.4 | 3.5 | GO:0042382 | paraspeckles(GO:0042382) |
0.3 | 3.0 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.3 | 1.0 | GO:0005760 | gamma DNA polymerase complex(GO:0005760) |
0.3 | 3.5 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.3 | 1.3 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.3 | 2.5 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.3 | 1.8 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.3 | 42.6 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.3 | 5.6 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.3 | 1.5 | GO:0000125 | PCAF complex(GO:0000125) |
0.3 | 1.5 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.3 | 2.0 | GO:1990246 | uniplex complex(GO:1990246) |
0.3 | 1.7 | GO:0016600 | flotillin complex(GO:0016600) |
0.3 | 7.7 | GO:0030057 | desmosome(GO:0030057) |
0.3 | 5.0 | GO:0036038 | MKS complex(GO:0036038) |
0.3 | 35.8 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.3 | 1.1 | GO:0071797 | LUBAC complex(GO:0071797) |
0.3 | 19.3 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.3 | 1.9 | GO:0070938 | contractile ring(GO:0070938) |
0.3 | 1.4 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.3 | 0.8 | GO:0035068 | nucleocytoplasmic shuttling complex(GO:0031074) micro-ribonucleoprotein complex(GO:0035068) |
0.3 | 1.9 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.3 | 2.1 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.3 | 6.1 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.3 | 6.6 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.3 | 12.7 | GO:0015030 | Cajal body(GO:0015030) |
0.3 | 1.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.3 | 0.5 | GO:0044393 | microspike(GO:0044393) |
0.2 | 1.5 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.2 | 1.7 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.2 | 1.7 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.2 | 2.6 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.2 | 1.2 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.2 | 2.5 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.2 | 8.9 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.2 | 15.2 | GO:0034707 | chloride channel complex(GO:0034707) |
0.2 | 3.8 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.2 | 3.8 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.2 | 1.8 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.2 | 4.4 | GO:0042627 | chylomicron(GO:0042627) |
0.2 | 20.9 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.2 | 2.1 | GO:0001741 | XY body(GO:0001741) |
0.2 | 24.2 | GO:0005884 | actin filament(GO:0005884) |
0.2 | 1.7 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.2 | 3.3 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.2 | 2.8 | GO:0000124 | SAGA complex(GO:0000124) |
0.2 | 3.8 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 1.4 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
0.2 | 2.2 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 2.7 | GO:0031209 | SCAR complex(GO:0031209) |
0.2 | 5.7 | GO:0005771 | multivesicular body(GO:0005771) |
0.2 | 1.3 | GO:0005638 | lamin filament(GO:0005638) |
0.2 | 2.6 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.2 | 1.9 | GO:0005767 | secondary lysosome(GO:0005767) autolysosome(GO:0044754) |
0.2 | 1.9 | GO:0001940 | male pronucleus(GO:0001940) |
0.2 | 3.2 | GO:0005685 | U1 snRNP(GO:0005685) |
0.2 | 2.0 | GO:0097542 | ciliary tip(GO:0097542) |
0.2 | 1.6 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.2 | 1.1 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.2 | 2.6 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.2 | 1.1 | GO:0098576 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) lumenal side of membrane(GO:0098576) |
0.2 | 3.0 | GO:0045120 | pronucleus(GO:0045120) |
0.2 | 6.6 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.2 | 1.6 | GO:0070545 | PeBoW complex(GO:0070545) |
0.2 | 1.0 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 9.6 | GO:0000791 | euchromatin(GO:0000791) |
0.2 | 3.4 | GO:0033202 | DNA helicase complex(GO:0033202) |
0.2 | 0.5 | GO:0032156 | septin cytoskeleton(GO:0032156) |
0.2 | 2.0 | GO:0044292 | dendrite terminus(GO:0044292) |
0.2 | 3.0 | GO:0005605 | basal lamina(GO:0005605) |
0.2 | 6.7 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.2 | 1.3 | GO:0070847 | core mediator complex(GO:0070847) |
0.2 | 57.5 | GO:0005925 | focal adhesion(GO:0005925) |
0.2 | 1.9 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 1.1 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.2 | 2.0 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
0.2 | 4.5 | GO:0016592 | mediator complex(GO:0016592) |
0.2 | 0.8 | GO:0035841 | growing cell tip(GO:0035838) new growing cell tip(GO:0035841) |
0.1 | 0.6 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 6.3 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.1 | 3.2 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.1 | 1.4 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.7 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.1 | 42.5 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.1 | 0.6 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.1 | 3.3 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 1.7 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 0.5 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 2.4 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 5.9 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.1 | 8.2 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 0.8 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.1 | 0.3 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.1 | 0.5 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 1.4 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 1.1 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.1 | 1.6 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.5 | GO:0044307 | dendritic branch(GO:0044307) |
0.1 | 0.9 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 0.8 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 4.6 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 1.1 | GO:0030686 | 90S preribosome(GO:0030686) |
0.1 | 2.0 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 4.6 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 0.9 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 7.6 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 5.9 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 9.6 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.4 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.1 | 1.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 2.2 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 1.0 | GO:0005861 | troponin complex(GO:0005861) |
0.1 | 0.2 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.1 | 1.0 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.1 | 0.4 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.1 | 0.3 | GO:0098835 | presynaptic endocytic zone(GO:0098833) presynaptic endocytic zone membrane(GO:0098835) |
0.1 | 6.2 | GO:0010008 | endosome membrane(GO:0010008) |
0.1 | 0.6 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 0.6 | GO:0005642 | annulate lamellae(GO:0005642) |
0.1 | 0.8 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.1 | 0.2 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.1 | 0.3 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 26.3 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 0.2 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.8 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.2 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.1 | 12.7 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 1.2 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 0.4 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.0 | 0.3 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.0 | 0.3 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 0.4 | GO:0002177 | manchette(GO:0002177) |
0.0 | 15.0 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.8 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 14.5 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.4 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.0 | 0.4 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 0.8 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 1.1 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 1.1 | GO:0072686 | mitotic spindle(GO:0072686) |
0.0 | 0.8 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.0 | 0.5 | GO:0035861 | site of double-strand break(GO:0035861) |
0.0 | 2.3 | GO:0005819 | spindle(GO:0005819) |
0.0 | 0.8 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 0.0 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.0 | 0.2 | GO:0032039 | integrator complex(GO:0032039) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.1 | 30.5 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
5.7 | 17.2 | GO:0035717 | chemokine (C-C motif) ligand 7 binding(GO:0035717) |
5.5 | 27.6 | GO:0042610 | CD8 receptor binding(GO:0042610) |
5.5 | 27.3 | GO:0019976 | interleukin-2 binding(GO:0019976) |
5.1 | 35.5 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
4.9 | 63.3 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
4.7 | 14.0 | GO:0098973 | structural constituent of synapse(GO:0098918) structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
4.7 | 46.7 | GO:0050786 | RAGE receptor binding(GO:0050786) |
4.2 | 12.6 | GO:0008457 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
4.0 | 36.3 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
3.8 | 34.5 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
3.7 | 7.5 | GO:0035478 | chylomicron binding(GO:0035478) |
3.5 | 10.5 | GO:0033680 | ATP-dependent DNA/RNA helicase activity(GO:0033680) |
3.5 | 44.9 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
3.4 | 6.9 | GO:0042497 | triacyl lipopeptide binding(GO:0042497) |
3.3 | 13.0 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
3.0 | 15.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
3.0 | 8.9 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
2.8 | 36.7 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
2.8 | 8.4 | GO:0032090 | Pyrin domain binding(GO:0032090) |
2.6 | 13.2 | GO:0004998 | transferrin receptor activity(GO:0004998) |
2.6 | 7.7 | GO:0050785 | advanced glycation end-product receptor activity(GO:0050785) |
2.4 | 9.6 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
2.4 | 7.1 | GO:0070122 | isopeptidase activity(GO:0070122) ubiquitin-like protein-specific isopeptidase activity(GO:0070138) SUMO-specific isopeptidase activity(GO:0070140) |
2.4 | 9.5 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
2.3 | 6.8 | GO:0035375 | zymogen binding(GO:0035375) |
2.3 | 9.0 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
2.2 | 26.8 | GO:0050700 | CARD domain binding(GO:0050700) |
2.2 | 55.6 | GO:0051400 | BH domain binding(GO:0051400) |
2.2 | 6.6 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
2.2 | 13.0 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
2.2 | 2.2 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
2.1 | 6.3 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
2.1 | 33.3 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
2.1 | 14.5 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
2.1 | 22.7 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
2.1 | 8.2 | GO:0015057 | thrombin receptor activity(GO:0015057) |
2.0 | 24.2 | GO:0008061 | chitin binding(GO:0008061) |
2.0 | 8.0 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
1.9 | 5.7 | GO:0005174 | CD40 receptor binding(GO:0005174) |
1.9 | 35.2 | GO:0042288 | MHC class I protein binding(GO:0042288) |
1.8 | 5.4 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
1.8 | 38.0 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
1.7 | 10.4 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
1.7 | 5.1 | GO:0019959 | interleukin-8 binding(GO:0019959) |
1.7 | 13.5 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
1.7 | 6.7 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
1.7 | 5.0 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
1.6 | 54.4 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
1.6 | 6.3 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
1.6 | 4.7 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
1.5 | 4.6 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
1.5 | 11.9 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
1.5 | 4.4 | GO:0035500 | MH2 domain binding(GO:0035500) |
1.5 | 5.8 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
1.5 | 4.4 | GO:0001847 | opsonin receptor activity(GO:0001847) |
1.5 | 10.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
1.4 | 15.8 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
1.4 | 7.1 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) |
1.4 | 25.6 | GO:0003993 | acid phosphatase activity(GO:0003993) |
1.4 | 7.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
1.4 | 5.7 | GO:0031721 | haptoglobin binding(GO:0031720) hemoglobin alpha binding(GO:0031721) |
1.4 | 15.3 | GO:0033691 | sialic acid binding(GO:0033691) |
1.4 | 4.1 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
1.3 | 6.7 | GO:0019767 | IgE receptor activity(GO:0019767) |
1.3 | 4.0 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
1.3 | 11.9 | GO:0042609 | CD4 receptor binding(GO:0042609) |
1.3 | 9.2 | GO:0015265 | urea channel activity(GO:0015265) |
1.3 | 9.2 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
1.3 | 6.5 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
1.3 | 3.9 | GO:0004686 | elongation factor-2 kinase activity(GO:0004686) |
1.3 | 54.0 | GO:0008009 | chemokine activity(GO:0008009) |
1.3 | 38.2 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
1.3 | 3.8 | GO:0004915 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
1.2 | 7.4 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
1.2 | 4.9 | GO:0097643 | amylin receptor activity(GO:0097643) |
1.2 | 3.5 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
1.2 | 6.9 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
1.1 | 3.4 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
1.1 | 10.2 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
1.1 | 17.9 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
1.1 | 5.5 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
1.1 | 7.7 | GO:0051425 | PTB domain binding(GO:0051425) |
1.1 | 36.8 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
1.1 | 62.1 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
1.1 | 3.2 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
1.1 | 18.0 | GO:0008301 | DNA binding, bending(GO:0008301) |
1.1 | 4.2 | GO:0070976 | TIR domain binding(GO:0070976) |
1.0 | 4.2 | GO:0032093 | SAM domain binding(GO:0032093) |
1.0 | 19.8 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
1.0 | 10.4 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
1.0 | 6.1 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
1.0 | 3.0 | GO:0036461 | BLOC-2 complex binding(GO:0036461) |
1.0 | 14.1 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
1.0 | 3.0 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
1.0 | 1.0 | GO:0019961 | interferon binding(GO:0019961) |
1.0 | 8.9 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
1.0 | 2.9 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
1.0 | 13.7 | GO:0030274 | LIM domain binding(GO:0030274) |
1.0 | 42.4 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.9 | 6.6 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.9 | 8.4 | GO:0016936 | galactoside binding(GO:0016936) |
0.9 | 23.2 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.9 | 3.6 | GO:0035827 | rubidium ion transmembrane transporter activity(GO:0035827) |
0.9 | 4.5 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.9 | 48.3 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.9 | 2.6 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.9 | 4.4 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.9 | 3.4 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.9 | 9.5 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.9 | 2.6 | GO:0052597 | diamine oxidase activity(GO:0052597) histamine oxidase activity(GO:0052598) methylputrescine oxidase activity(GO:0052599) propane-1,3-diamine oxidase activity(GO:0052600) |
0.8 | 3.4 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.8 | 4.2 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.8 | 5.9 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.8 | 5.8 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) hemi-methylated DNA-binding(GO:0044729) |
0.8 | 4.1 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.8 | 6.4 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.8 | 3.2 | GO:0034597 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
0.8 | 49.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.8 | 42.8 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.8 | 2.4 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.8 | 14.2 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.8 | 2.3 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.8 | 8.4 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.7 | 12.6 | GO:0005522 | profilin binding(GO:0005522) |
0.7 | 8.1 | GO:0035197 | siRNA binding(GO:0035197) |
0.7 | 2.2 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.7 | 2.2 | GO:0004418 | hydroxymethylbilane synthase activity(GO:0004418) |
0.7 | 12.0 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.7 | 16.2 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.7 | 2.1 | GO:0019002 | GMP binding(GO:0019002) |
0.7 | 52.0 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.7 | 43.4 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.7 | 9.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.7 | 4.2 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.7 | 4.9 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.7 | 2.8 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.7 | 6.2 | GO:0045545 | syndecan binding(GO:0045545) |
0.7 | 2.7 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.7 | 3.4 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.7 | 6.8 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.7 | 6.8 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.7 | 3.4 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.7 | 7.4 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.7 | 5.4 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.7 | 4.0 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.7 | 0.7 | GO:0031753 | endothelial differentiation G-protein coupled receptor binding(GO:0031753) Edg-2 lysophosphatidic acid receptor binding(GO:0031755) |
0.7 | 2.6 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
0.7 | 9.9 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.7 | 7.9 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.6 | 6.5 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.6 | 6.5 | GO:0004064 | arylesterase activity(GO:0004064) |
0.6 | 2.6 | GO:0046403 | polynucleotide 3'-phosphatase activity(GO:0046403) |
0.6 | 3.9 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.6 | 6.4 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.6 | 3.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.6 | 3.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.6 | 2.5 | GO:0030519 | snoRNP binding(GO:0030519) |
0.6 | 2.5 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.6 | 4.3 | GO:0005499 | vitamin D binding(GO:0005499) |
0.6 | 10.4 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.6 | 15.9 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.6 | 1.8 | GO:0042936 | dipeptide transporter activity(GO:0042936) |
0.6 | 9.7 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.6 | 5.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.6 | 7.2 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.6 | 14.4 | GO:0001618 | virus receptor activity(GO:0001618) |
0.6 | 2.4 | GO:0048495 | Roundabout binding(GO:0048495) |
0.6 | 1.2 | GO:0097677 | STAT family protein binding(GO:0097677) |
0.6 | 5.4 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.6 | 1.8 | GO:0005333 | norepinephrine transmembrane transporter activity(GO:0005333) |
0.6 | 2.3 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.6 | 2.3 | GO:0047522 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.6 | 7.6 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.6 | 18.3 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.6 | 1.7 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.6 | 3.4 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.6 | 4.0 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.6 | 1.7 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
0.6 | 1.7 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.6 | 9.1 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.6 | 6.8 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.6 | 3.9 | GO:0030172 | troponin C binding(GO:0030172) |
0.6 | 18.2 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.5 | 7.1 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.5 | 69.0 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.5 | 4.4 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.5 | 5.4 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.5 | 1.6 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.5 | 2.7 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.5 | 3.7 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.5 | 10.5 | GO:0043274 | phospholipase binding(GO:0043274) |
0.5 | 13.1 | GO:0017166 | vinculin binding(GO:0017166) |
0.5 | 2.0 | GO:0086038 | calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086038) |
0.5 | 1.0 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
0.5 | 7.6 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.5 | 1.5 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.5 | 2.0 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
0.5 | 28.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.5 | 1.0 | GO:0048030 | disaccharide binding(GO:0048030) |
0.5 | 9.9 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.5 | 5.4 | GO:0042731 | PH domain binding(GO:0042731) |
0.5 | 1.5 | GO:0002134 | pyrimidine nucleoside binding(GO:0001884) UTP binding(GO:0002134) carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) pyrimidine ribonucleoside binding(GO:0032551) |
0.5 | 3.4 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.5 | 2.4 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.5 | 3.4 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.5 | 3.9 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.5 | 8.1 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.5 | 3.3 | GO:0043199 | sulfate binding(GO:0043199) |
0.5 | 1.4 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
0.5 | 1.4 | GO:0052595 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
0.5 | 3.2 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.4 | 2.7 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.4 | 1.3 | GO:0070039 | rRNA (guanosine-2'-O-)-methyltransferase activity(GO:0070039) |
0.4 | 2.7 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.4 | 2.7 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.4 | 1.3 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.4 | 5.7 | GO:0001054 | RNA polymerase I activity(GO:0001054) RNA polymerase II activity(GO:0001055) |
0.4 | 2.2 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.4 | 3.0 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.4 | 1.3 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.4 | 2.5 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.4 | 2.5 | GO:0070320 | RNA polymerase I transcription factor binding(GO:0001179) inward rectifier potassium channel inhibitor activity(GO:0070320) |
0.4 | 2.9 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.4 | 2.9 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.4 | 2.9 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.4 | 4.1 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.4 | 14.9 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.4 | 20.7 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.4 | 2.9 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.4 | 2.5 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.4 | 1.6 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.4 | 6.9 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.4 | 9.3 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.4 | 17.2 | GO:0019843 | rRNA binding(GO:0019843) |
0.4 | 13.8 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.4 | 3.5 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.4 | 14.5 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.4 | 4.6 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.4 | 1.5 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.4 | 2.6 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.4 | 51.0 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.4 | 1.8 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.4 | 1.5 | GO:0008493 | tetracycline transporter activity(GO:0008493) |
0.4 | 4.4 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.4 | 10.2 | GO:0001968 | fibronectin binding(GO:0001968) |
0.4 | 1.4 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.4 | 1.8 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.4 | 2.5 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.4 | 43.8 | GO:0005178 | integrin binding(GO:0005178) |
0.4 | 4.2 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.4 | 24.9 | GO:0035064 | methylated histone binding(GO:0035064) |
0.3 | 7.0 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.3 | 1.0 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.3 | 4.4 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.3 | 2.0 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.3 | 3.7 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.3 | 1.0 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.3 | 3.3 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.3 | 2.3 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.3 | 4.3 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.3 | 1.3 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.3 | 1.7 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
0.3 | 6.9 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.3 | 7.2 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.3 | 10.5 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.3 | 7.2 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.3 | 2.3 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.3 | 11.4 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.3 | 2.9 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.3 | 1.9 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.3 | 1.0 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.3 | 5.4 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.3 | 1.3 | GO:0050436 | microfibril binding(GO:0050436) |
0.3 | 120.8 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.3 | 2.8 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.3 | 3.1 | GO:0051766 | inositol trisphosphate kinase activity(GO:0051766) |
0.3 | 2.8 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.3 | 1.9 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.3 | 1.2 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.3 | 1.8 | GO:0038049 | glucocorticoid receptor activity(GO:0004883) transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
0.3 | 0.3 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.3 | 18.0 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.3 | 2.1 | GO:0000150 | recombinase activity(GO:0000150) |
0.3 | 0.3 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.3 | 6.2 | GO:0032183 | SUMO binding(GO:0032183) |
0.3 | 1.5 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.3 | 0.9 | GO:0001147 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
0.3 | 5.9 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.3 | 2.5 | GO:0032052 | bile acid binding(GO:0032052) |
0.3 | 10.6 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.3 | 2.8 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.3 | 1.6 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.3 | 0.8 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
0.3 | 2.2 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.3 | 1.4 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.3 | 0.8 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.3 | 5.7 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.3 | 1.6 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.3 | 5.1 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.3 | 1.9 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.3 | 1.3 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
0.3 | 0.8 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.3 | 1.8 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.3 | 21.7 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.3 | 1.8 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.3 | 21.1 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.3 | 8.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.3 | 2.1 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.3 | 1.0 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.3 | 0.5 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
0.3 | 0.8 | GO:0032190 | acrosin binding(GO:0032190) |
0.2 | 1.2 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.2 | 40.3 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.2 | 0.7 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.2 | 2.4 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 1.0 | GO:0086077 | gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
0.2 | 5.0 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.2 | 3.1 | GO:0050692 | DBD domain binding(GO:0050692) |
0.2 | 29.2 | GO:0004519 | endonuclease activity(GO:0004519) |
0.2 | 19.5 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.2 | 1.9 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 1.2 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.2 | 0.9 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.2 | 2.5 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.2 | 1.6 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.2 | 5.4 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.2 | 2.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.2 | 3.5 | GO:0015026 | coreceptor activity(GO:0015026) |
0.2 | 2.0 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.2 | 2.8 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.2 | 0.9 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.2 | 1.9 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.2 | 1.3 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.2 | 0.4 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.2 | 3.3 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.2 | 2.1 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.2 | 12.9 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
0.2 | 12.2 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.2 | 10.1 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.2 | 3.6 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.2 | 1.8 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.2 | 2.0 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.2 | 4.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 3.6 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.2 | 2.4 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.2 | 4.4 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.2 | 2.2 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.2 | 0.8 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.2 | 4.3 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.2 | 0.6 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.2 | 2.2 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.2 | 2.0 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.2 | 3.5 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.2 | 4.2 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.2 | 7.5 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.2 | 3.5 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.2 | 22.4 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 1.1 | GO:0008142 | oxysterol binding(GO:0008142) |
0.2 | 1.1 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.2 | 1.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.2 | 10.8 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.2 | 2.8 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.2 | 8.6 | GO:0004601 | peroxidase activity(GO:0004601) |
0.2 | 8.5 | GO:0003823 | antigen binding(GO:0003823) |
0.2 | 125.8 | GO:0000987 | core promoter proximal region sequence-specific DNA binding(GO:0000987) |
0.2 | 2.5 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.2 | 1.3 | GO:0031014 | troponin T binding(GO:0031014) |
0.2 | 2.5 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.2 | 0.7 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.2 | 19.6 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.2 | 1.8 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.2 | 0.9 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.2 | 5.8 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.2 | 3.3 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.2 | 0.7 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.2 | 1.4 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.2 | 0.7 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.2 | 2.0 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.2 | 5.0 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.2 | 0.9 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.2 | 1.6 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.2 | 1.5 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.2 | 4.9 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.2 | 4.5 | GO:0015491 | cation:cation antiporter activity(GO:0015491) |
0.1 | 0.6 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.1 | 2.5 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 1.6 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.1 | 8.7 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 0.9 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 3.3 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 1.5 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.9 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 9.4 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 3.4 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 0.4 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.1 | 0.4 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
0.1 | 7.0 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 5.2 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 1.2 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 3.2 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.1 | 1.4 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.1 | 1.3 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 2.5 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 2.5 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 0.9 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 4.4 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 5.1 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.1 | 0.9 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 43.7 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 1.6 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 1.1 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 0.5 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.1 | 1.1 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 0.9 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 54.7 | GO:0044212 | transcription regulatory region DNA binding(GO:0044212) |
0.1 | 2.5 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.1 | 1.7 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 0.8 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 2.0 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 5.1 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 0.8 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.1 | 0.4 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 1.0 | GO:0004579 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.9 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 26.5 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 1.3 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.1 | 3.2 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 23.6 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.1 | 0.7 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.1 | 2.6 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.2 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 1.5 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 1.2 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 1.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.5 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.1 | 3.3 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.9 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.1 | 32.7 | GO:0003779 | actin binding(GO:0003779) |
0.1 | 1.1 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 0.1 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 0.5 | GO:0043236 | laminin binding(GO:0043236) |
0.1 | 1.8 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.6 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.4 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
0.1 | 0.4 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.1 | 0.6 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.6 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 0.6 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 1.3 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.1 | 0.2 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.1 | 0.2 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.1 | GO:0016715 | dopamine beta-monooxygenase activity(GO:0004500) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 0.2 | GO:0003999 | adenine binding(GO:0002055) adenine phosphoribosyltransferase activity(GO:0003999) |
0.1 | 0.5 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.0 | 0.7 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 0.2 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.0 | 2.0 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.5 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.0 | 0.2 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.0 | 0.7 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.3 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.3 | GO:0009881 | G-protein coupled photoreceptor activity(GO:0008020) photoreceptor activity(GO:0009881) |
0.0 | 0.2 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.0 | 0.1 | GO:0071253 | connexin binding(GO:0071253) |
0.0 | 1.0 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 0.2 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.0 | 0.6 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.0 | 0.2 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.0 | 0.1 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 1.2 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 1.8 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.0 | 0.5 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.0 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 2.4 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.1 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.7 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.0 | 0.0 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
0.0 | 0.2 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.0 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.0 | GO:0008147 | structural constituent of bone(GO:0008147) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 255.8 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
2.4 | 39.1 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
2.1 | 80.6 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
1.9 | 60.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
1.8 | 112.4 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
1.8 | 48.8 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
1.6 | 73.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
1.6 | 23.4 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
1.3 | 44.8 | PID CONE PATHWAY | Visual signal transduction: Cones |
1.2 | 55.0 | PID CD40 PATHWAY | CD40/CD40L signaling |
1.2 | 51.2 | PID BCR 5PATHWAY | BCR signaling pathway |
1.1 | 32.5 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
1.0 | 13.6 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
1.0 | 42.4 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
1.0 | 111.6 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
1.0 | 37.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
1.0 | 2.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
1.0 | 28.9 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
1.0 | 26.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
1.0 | 12.7 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.9 | 11.4 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.9 | 49.5 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.9 | 72.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.8 | 5.0 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.8 | 9.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.7 | 9.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.7 | 6.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.7 | 10.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.7 | 3.4 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.7 | 51.3 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.7 | 4.6 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.6 | 12.3 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.6 | 9.6 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.6 | 20.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.6 | 7.7 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.6 | 24.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.6 | 9.9 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.6 | 17.9 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.6 | 12.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.6 | 5.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.6 | 33.8 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.6 | 10.2 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.5 | 4.3 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.5 | 9.5 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.5 | 6.8 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.5 | 40.2 | PID E2F PATHWAY | E2F transcription factor network |
0.5 | 6.7 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.5 | 7.7 | PID MYC PATHWAY | C-MYC pathway |
0.5 | 23.3 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.5 | 1.4 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.5 | 16.1 | PID ATR PATHWAY | ATR signaling pathway |
0.5 | 5.4 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.4 | 3.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.4 | 6.1 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.4 | 37.4 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.4 | 28.0 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.4 | 1.7 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.4 | 23.8 | PID P53 REGULATION PATHWAY | p53 pathway |
0.4 | 0.8 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.4 | 10.0 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.4 | 13.8 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.4 | 4.6 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.4 | 5.6 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.4 | 5.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.3 | 22.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.3 | 4.4 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.3 | 7.4 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.3 | 2.0 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.3 | 5.0 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.3 | 6.8 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.3 | 5.5 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.3 | 2.9 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.3 | 4.5 | PID ARF6 PATHWAY | Arf6 signaling events |
0.3 | 2.6 | PID RHOA PATHWAY | RhoA signaling pathway |
0.3 | 7.7 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.2 | 4.0 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 3.0 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 1.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 4.5 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.2 | 6.7 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.2 | 3.6 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.2 | 3.1 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.2 | 44.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 3.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 14.5 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.2 | 3.8 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 4.9 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.2 | 5.4 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.2 | 0.9 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.2 | 4.1 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.2 | 19.9 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.2 | 3.9 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.2 | 6.5 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 6.9 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 0.3 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 4.4 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 3.6 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 1.4 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 3.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 3.2 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 2.3 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 0.5 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 17.6 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 0.9 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 3.1 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 0.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 2.0 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 2.6 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 0.9 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 0.4 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 0.7 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.7 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 4.8 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 1.3 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 2.4 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 5.8 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.8 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.4 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.3 | 124.4 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
4.7 | 47.2 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
2.7 | 5.4 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
2.5 | 9.8 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
2.2 | 13.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
2.0 | 14.3 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
2.0 | 17.8 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
1.9 | 107.9 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
1.9 | 108.7 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
1.9 | 5.6 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
1.9 | 29.8 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
1.8 | 18.0 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
1.8 | 24.5 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
1.7 | 21.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
1.6 | 26.2 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
1.6 | 26.2 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
1.6 | 49.4 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
1.5 | 27.7 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
1.5 | 27.3 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
1.5 | 28.4 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
1.5 | 26.9 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
1.5 | 22.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
1.4 | 8.4 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
1.4 | 20.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
1.3 | 52.0 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
1.3 | 63.8 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
1.3 | 16.8 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
1.3 | 64.1 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
1.3 | 51.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
1.2 | 28.2 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
1.2 | 4.7 | REACTOME DEFENSINS | Genes involved in Defensins |
1.1 | 30.9 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
1.1 | 64.7 | REACTOME G1 PHASE | Genes involved in G1 Phase |
1.1 | 3.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
1.0 | 7.0 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
1.0 | 4.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
1.0 | 29.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
1.0 | 10.7 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
1.0 | 2.9 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.9 | 6.5 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.9 | 14.7 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.9 | 9.1 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.8 | 14.1 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.8 | 1.6 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.8 | 4.6 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.7 | 3.7 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.7 | 9.7 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.7 | 10.8 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.7 | 84.4 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.7 | 9.7 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.7 | 5.3 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.7 | 39.4 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.6 | 29.9 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.6 | 27.3 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.6 | 24.0 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.6 | 7.1 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.6 | 8.3 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.6 | 4.1 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.6 | 3.5 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.6 | 6.9 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.5 | 19.5 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.5 | 8.0 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.5 | 18.3 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.5 | 1.4 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.5 | 10.9 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.4 | 8.8 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.4 | 13.6 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.4 | 7.4 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.4 | 6.1 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.4 | 12.9 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.4 | 4.6 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.4 | 5.3 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.4 | 15.2 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.4 | 4.2 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.4 | 18.6 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.4 | 8.8 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.4 | 24.2 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.3 | 4.3 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.3 | 5.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.3 | 2.8 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.3 | 2.9 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.3 | 6.9 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.3 | 10.3 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.3 | 12.1 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.3 | 5.2 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.3 | 15.9 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.3 | 7.5 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.3 | 2.9 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.2 | 54.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.2 | 3.2 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.2 | 14.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.2 | 6.8 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 2.2 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.2 | 3.2 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.2 | 4.6 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.2 | 8.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.2 | 8.7 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.2 | 5.0 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.2 | 17.6 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.2 | 1.6 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.2 | 15.8 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.2 | 3.1 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.2 | 2.6 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.2 | 3.1 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.2 | 4.8 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.2 | 5.4 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 3.1 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.2 | 2.8 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.2 | 1.7 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 13.3 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 3.8 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.1 | 11.7 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 2.6 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 4.8 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.1 | 0.5 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 0.6 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.1 | 2.3 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 4.6 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 1.2 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 7.5 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 2.9 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.1 | 12.7 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 1.2 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 4.6 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 2.2 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 3.1 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.1 | 1.1 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 3.1 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 1.3 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 1.2 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.1 | 3.4 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 0.7 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.1 | 0.7 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
0.0 | 0.3 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.2 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.6 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.7 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.0 | 0.5 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 0.6 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.0 | 0.8 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.0 | 2.8 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 1.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.5 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 1.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.3 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 1.1 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.1 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.0 | 0.2 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.2 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |